AUTHOR: Biomed Mom TITLE: Serotonin's effects on multiple body systems DATE: 1/15/2009 07:15:00 AM ----- BODY:
One Dangerous Deficiency Links IBS, Migraines, and More Health News By VRP Staff When you think of serotonin deficiency, the first consequence that might spring to mind is depression. And if so, you’d be right. But there’s more to this neurotransmitter than meets the eye—a lot more. Migraines, irritable bowel syndrome, fibromyalgia, obesity, even asthma… believe it or not, all of these serious conditions can be traced back to depleted serotonin levels. And the effects on your body can be as damaging as they are diverse. Serotonin is one of your brain’s most crucial messengers. It’s released by your neurons to send signals to other neurons, after which it’s returned to its original parent neuron to be reused. But if your levels are low, serotonin’s time on your synapse is cut short. It’s recaptured before it can finish its job—at a very high cost to your health, mentally and physically. In addition to depression, low levels of serotonin–and its precursor tryptophan–have been linked to binge eating, carbohydrate cravings, and weight gain.1 Studies show that obese and overweight diabetic patients have levels that are well below normal–and in clinical trials, increased brain serotonin led to both reduced caloric intake and resulting weight loss.2–4 But it’s not just your waistline that benefits from this critical neurotransmitter. Studies have shown that increasing serotonin levels can fight insomnia by improving sleep continuity.5 Research also shows that increased serotonin relieves migraines as effectively as standard drug therapy and aids in relief of chronic tension headaches.6–7 This same ability has made it a unique target in the treatment of fibromyalgia, with serotonin deficiency implicated for lower pain thresholds and higher clinical measures of perceived pain in patients.8–10 In an even more surprising connection, serotonin has also been identified as a major player in gut motility.11–12 Special serotonin–releasing cells can be found throughout your digestive system, responsible for stimulating peristaltic motion and pushing waste through your digestive tract.13 Even the development and severity of asthma has been linked to depression, anxiety, and low–serotonin related disorders—revealing yet another function under this neurotransmitter’s powerful influence.14 Proper levels of serotonin are essential for your health—and one way to ensure higher levels of this neurotransmitter is by boosting your intake of tryptophan, an essential amino acid found in high–protein foods that is responsible for serotonin synthesis in your brain. Research has shown that supplementing with tryptophan (and its metabolite 5–hydroxytryptophan, or 5–HTP) can replenish serotonin naturally and effectively—easing depression, anxiety, migraines, insomnia, and fibromyalgia symptoms in several clinical studies.15–17 References: 1. Gendall KA, Joyce PR. Meal–induced changes in tryptophan:LNAA ratio: effects on craving and binge eating. Eat Behav. 2000 Sep;1(1):53–62. 2. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty–four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003 May;77(5):1112–1118. 3. Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5–hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76(2):109–117. 4. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5–hydroxytryptophan. Am J Clin Nutr 1992 Nov;56(5):863–867. 5. Riemann D, Vorderholzer U. Treatment of depression and sleep disorders. Significance of serotonin and L–tryptophan in pathophysiology and therapy. Fortschr Med. 1998 Nov;116(32):40–42. 6. Titus F, Dávalos A, Alom J, Codina A. 5–Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol. 1986;25(5):327–329. 7. Ribeiro CA. L–5–Hydroxytryptophan in the prophylaxis of chronic tension–type headache: a double–blind, randomized, placebo–controlled study. For the Portuguese Head Society. Headache. 2000 Jun;40(6):451–456. 8. Birdsall TC. 5–Hydroxytryptophan: a clinically–effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271–280. 9. Hrycaj P, Stratz T, Muller W. Platelet 3Himipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1993;20:1986–1988. [letter] 10. Russell IJ, Michalek JE, Vipraio GA, et al. Platelet 3H–imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104–109. 11. Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008 Feb;4(1):41–48. 12. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Minneap). 1999 Jul 15;34(7):31–32,35–38,41–42. 13. Grider JR. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5–HT4 agonist tegaserod. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G319–G327. 14. Goodwin RD, Sourander A, Duarte CS, et al. Do mental health problems in childhood predict chronic physical conditions among males in early adulthood? Evidence from a community–based prospective study. Psychol Med. 2008 May 28:1–11. 15. Poldinger W, Calanchini B, Schwarz W. A functional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5–hydroxytryptophan and fluvoxamine. Psychopathology. 1991;24:53–81. 16. Kahn RS, Westenberg HG. L–5–hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord. 1985 Mar–Apr;8(2):197–200. 17. Puttini PS, Caruso I. Primary fibromyalgia and 5–hydroxy–L–tryptophan: a 90 day open study. J Int Med Res. 1992;20:182–189.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: PTSD and neurobiology DATE: 4/29/2008 05:05:00 PM ----- BODY:
The Body Keeps The Score:
Memory & the Evolving Psychobiology of Post Traumatic Stress
by Bessel van der Kolk


Bessel A. van der Kolk, MD.
Harvard Medical School
HRI Trauma Center
227 Babcock Street
Boston, MA 02146

This is a version of an article first published in the Harvard Review of Psychiatry, 1994, 1(5), 253-265. Note that this online version may have minor differences from the published version.
The author wishes to thank Rita Fisler, Ed.M. for her editorial assistance.
Background

For more than a century, ever since people's responses to overwhelming experiences were first systematically explored, it has been noted that the psychological effects of trauma are expressed as changes in the biological stress response. In 1889, Pierre Janet (1), postulated that intense emotional reactions make events traumatic by interfering with the integration of the experience into existing memory schemes. Intense emotions, Janet thought, cause memories of particular events to be dissociated from consciousness, and to be stored, instead, as visceral sensations (anxiety and panic), or as visual images (nightmares and flashbacks). Janet also observed that traumatized patients seemed to react to reminders of the trauma with emergency responses that had been relevant to the original threat, but that had no bearing on current experience. He noted that victims had trouble learning from experience: unable to put the trauma behind them, their energies were absorbed by keeping their emotions under control at the expense of paying attention to current exigencies. They became fixated upon the past, in some cases by being obsessed with the trauma, but more often by behaving and feeling like they were traumatized over and over again without being able to locate the origins of these feelings (2,3).

Freud also considered the tendency to stay fixated on the trauma to be biologically based: "After severe shock.. the dream life continually takes the patient back to the situation of his disaster from which he awakens with renewed terror.. the patient has undergone a physical fixation to the trauma"(4). Pavlov's investigations continued the tradition of explaining the effects of trauma as the result of lasting physiological alterations. He, and others employing his paradigm, coined the term "defensive reaction" for a cluster of innate reflexive responses to environmental threat (5). Many studies have shown how the response to potent environmental stimuli (unconditional stimuli-US) becomes a conditioned reaction. After repeated aversive stimulation, intrinsically non-threatening cues associated with the trauma (conditional stimuli-CS) become capable of eliciting the defensive reaction by themselves (conditional response-CR). A rape victim may respond to conditioned stimuli, such as the approach by an unknown man, as if she were about to be raped again, and experience panic. Pavlov also pointed out that individual differences in temperament accounted for the diversity of long term adaptations to trauma.

Abraham Kardiner(6), who first systematically defined posttraumatic stress for American audiences, noted that sufferers from "traumatic neuroses" develop an enduring vigilance for and sensitivity to environmental threat, and stated that "the nucleus of the neurosis is a physioneurosis. This is present on the battlefield and during the entire process of organization; it outlives every intermediary accommodative device, and persists in the chronic forms. The traumatic syndrome is ever present and unchanged". In "Men under Stress", Grinker and Spiegel (7) catalogue the physical symptoms of soldiers in acute posttraumatic states: flexor changes in posture, hyperkinesis, "violently propulsive gait", tremor at rest, masklike facies, cogwheel rigidity, gastric distress, urinary incontinence, mutism, and a violent startle reflex. They noted the similarity between many of these symptoms and those of diseases of the extrapyramidal motor system. Today we can understand them as the result of stimulation of biological systems, particularly of ascending amine projections. Contemporary research on the biology of PTSD, generally uninformed by this earlier research, confirms that there are persistent and profound alterations in stress hormones secretion and memory processing in people with PTSD.
The Symptomatology of PTSD

Starting with Kardiner(6), and closely followed by Lindemann (8), a vast literature on combat trauma, crimes, rape, kidnapping, natural disasters, accidents and imprisonment have shown that the trauma response is bimodal: hypermnesia, hyper-reactivity to stimuli and traumatic reexperiencing coexist with psychic numbing, avoidance, amnesia and anhedonia (9,10,11,12). These responses to extreme experiences are so consistent across traumatic stimuli that this biphasic reaction appears to be the normative response to any overwhelming and uncontrollable experience. In many people who have undergone severe stress, the post-traumatic response fades over time, while it persists in others. Much work remains to be done to spell out issues of resilience and vulnerability, but magnitude of exposure, prior trauma, and social support appear to be the three most significant predictors for developing chronic PTSD (13,14).

In an apparent attempt to compensate for chronic hyperarousal, traumatized people seem to shut down: on a behavioral level, by avoiding stimuli reminiscent of the trauma; on a psychobiological level, by emotional numbing, which extends to both trauma-related, and everyday experience (15). Thus, people with chronic PTSD tend to suffer from numbing of responsiveness to the environment, punctuated by intermittent hyperarousal in response to conditional traumatic stimuli. However, as Pitman has pointed out (16), in PTSD, the stimuli that precipitate emergency responses may not be conditional enough: many triggers not directly related to the traumatic experience may precipitate extreme reactions. Thus, people with PTSD suffer both from generalized hyperarousal and from physiological emergency reactions to specific reminders(9,10) The loss of affective modulation that is so central in PTSD mayhelp explain the observation that traumatized people lose the capacity to utilize affect states as signals (18). Instead of using feelings as cues to attend to incoming information, in people with PTSD arousal is likely to precipitate flight or fight reactions (19). Thus, they are prone to go immediately from stimulus to response without making the necessary psychological assessment of the meaning of what is going on. This makes them prone to freeze, or, alternatively, to overreact and intimidate others in response to minor provocations (12,20).
Psychophysiology

Abnormal psychophysiological responses in PTSD have been demonstrated on two different levels: 1) in response to specific reminders of the trauma and 2) in response to intense, but neutral stimuli, such as acoustic startle. The first paradigm implies heightened physiological arousal to sounds, images, and thoughts related to specific traumatic incidents. A large number of studies have confirmed that traumatized individuals respond to such stimuli with significant conditioned autonomic reactions, such as heart rate, skin conductance and blood pressure (20,21,22,23, 24,25). The highly elevated physiological responses that accompany the recall of traumatic experiences that happened years, and sometimes decades before, illustrate the intensity and timelessness with which traumatic memories continue to affect current experience (3,16). This phenomenon has generally been understood in the light of Peter Lang's work (26) which shows that emotionally laden imagery correlates with measurable autonomic responses. Lang has proposed that emotional memories are stored as "associative networks", that are activated when a person is confronted with situations that stimulate a sufficient number of elements that make up these networks. One significant measure of treatment outcome that has become widely accepted in recent years is a decrease in physiological arousal in response to imagery related to the trauma (27). However, Shalev et al (28) have shown that desensitization to specific trauma-related mental images does not necessarily generalize to recollections of other traumatic events, as well.

Kolb (29) was the first to propose that excessive stimulation of the CNS at the time of the trauma may result in permanent neuronal changes that have a negative effect on learning, habituation, and stimulus discrimination. These neuronal changes would not depend on actual exposure to reminders of the trauma for expression. The abnormal startle response characteristic of PTSD (10) exemplifies such neuronal changes.

Despite the fact that an abnormal acoustic startle response (ASR) has been seen as a cardinal feature of the trauma response for over half a century, systematic explorations of the ASR in PTSD have just begun. The ASR consists of a characteristic sequence of muscular and autonomic responses elicited by sudden and intense stimuli (30,31). The neuronal pathways involved consist of only a small number of mediating synapses between the receptor and effector and a large projection to brain areas responsible for CNS activation and stimulus evaluation (31). The ASR is mediated by excitatory amino acids such as glutamate and aspartate and is modulated by a variety of neurotransmitters and second messengers at both the spinal and supraspinal level (32). Habituation of the ASR in normals occurs after 3 to 5 presentations (30).

Several studies have demonstrated abnormalities in habituation to the ASR in PTSD (33,34,35,36). Shalev et al (33) found a failure to habituate both to CNS and ANS-mediated responses to ASR in 93% of the PTSD group, compared with 22% of the control subjects. Interestingly, people who previously met criteria for PTSD, but no longer do so now, continue to show failure of habituation of the ASR (van der Kolk et al, unpublished data; Pitman et al, unpublished data), which raises the question whether abnormal habituation to acoustic startle is a marker of, or a vulnerability factor for developing PTSD.

The failure to habituate to acoustic startle suggests that traumatized people have difficulty evaluating sensory stimuli, and mobilizing appropriate levels of physiological arousal(30). Thus, the inability of people with PTSD to properly integrate memories of the trauma and, instead, to get mired in a continuous reliving of the past, is mirrored physiologically in the misinterpretation of innocuous stimuli, such as the ASR, as potential threats.
The Hormonal Stress Response & the Psychobiology of PTSD

Post Traumatic Stress Disorder develops following exposure to events that are intensely distressing. Intense stress is accompanied by the release of endogenous, stress-responsive neurohormones, such as cortisol, epinephrine and norepinephrine (NE), vasopressin, oxytocin and endogenous opioids. These stress hormones help the organism mobilize the required energy to deal with the stress, ranging from increased glucose release to enhanced immune function. In a well-functioning organism, stress produces rapid and pronounced hormonal responses. However, chronic and persistent stress inhibits the effectiveness of the stress response and induces desensitization (37).

Much still remains to be learned about the specific roles of the different neurohormones in the stress response. NE is secreted by the Locus Coeruleus(LC) and distributed through much of the CNS, particularly the neocortex and the limbic system, where it plays a role in memory consolidation and helps initiate fight/ flight behaviors. Adrenocorticotropin (ACTH) is released from the anterior pituitary, and activates a cascade of reactions, eventuating in release of glucocorticoids from the adrenals. The precise interrelation between Hypothalamic-Pituitary-Adrenal (HPA) Axis hormones and the catecholamines in the stress response is not entirely clear, but it is known that stressors that activate NE neurons also increase CRF concentrations in the LC (38), while intracerebral ventricular infusion of CRF increases NE in the forebrain (39). Glucocorticoids and catecholamines may modulate each other's effects: in acute stress, cortisol helps regulate stress hormone release via a negative feedback loop to the hippocampus, hypothalamus and pituitary (40) and there is evidence that corticosteroids normalize catecholamine-induced arousal in limbic midbrain structures in response to stress (41). Thus, the simultaneous activation of corticosteroids and catecholamines could stimulate active coping behaviors, while increased arousal in the presence of low glucocorticoid levels may promote undifferentiated fight or flight reactions (42).

While acute stress activates the HPA axis and increases glucocorticoid levels, organisms adapt to chronic stress by activating a negative feedback loop that results in 1) decreased resting glucocorticoid levels in chronically stressed organisms, (43), 2) decreased glucocorticoid secretion in response to subsequent stress (42), and 3) increased concentration of glucocorticoid receptors in the hippocampus (44). Yehuda has suggested that increased concentration of glucocorticoid receptors could facilitate a stronger glucocorticoid negative feedback, resulting in a more sensitive HPA axis and a faster recovery from acute stress (45).

Chronic exposure to stress affects both acute and chronic adaptation: it permanently alters how an organism deals with its environment on a day-to-day basis, and it interferes with how it copes with subsequent acute stress (45).
Neuroendocrine Abnormalities in PTSD

Since there is an extensive animal literature on the effects of inescapable stress on the biological stress response of other species, such as monkeys and rats, much of the biological research on people with PTSD has focussed on testing the applicability of those research findings to people with PTSD (46,47). People with PTSD, like chronically and inescapbly shocked animals, seem to suffer from a persistent activation of the biological stress response upon exposure to stimuli reminiscent of the trauma.

1) Catecholamines. Neuroendocrine studies of Vietnam veterans with PTSD have found good evidence for chronically increased sympathetic nervous system activity in PTSD. One study (48) found elevated 24h excretions of urinary NE and epinephrine in PTSD combat veterans compared with patients with other psychiatric diagnoses. While Pitman & Orr (49) did not replicate these findings in 20 veterans and 15 combat controls, the mean urinary NE excretion values in their combat controls (58.0 ug/day) were substantially higher than those previously reported in normal populations. The expected compensatory downregulation of adrenergic receptors in response to increased levels of norepinephrine was confirmed by a study that found decreased platelet alpha-2 adrenergic receptors in combat veterans with PTSD, compared with normal controls (50). Another study also found an abnormally low alpha-2 adrenergic receptor-mediated adenylate cyclase signal transduction (51). In a recent study Southwick et al (52) used yohimbine injections (0.4 mg/kg), which activate noradrenergic neurons by blocking the alpha-2 auto- receptor, to study noradrenergic neuronal dysregulation in Vietnam veterans with PTSD. Yohimbine precipitated panic attacks in 70% of subjects and flashbacks in 40%. Subjects responded with larger increases in plasma MHPG than controls. Yohimbine precipitated significant increases in all PTSD symptoms.

2) Corticosteroids. Two studies have shown that veterans with PTSD have low urinary cortisol excretion, even when they have comorbid major depressive disorder (42,53). One study failed to replicate this finding (49). In a series of studies, Yehuda et al (42,54) found increased numbers of lymphocyte glucocorticoid receptors in Vietnam veterans with PTSD. Interestingly, the number of glucocorticoid receptors was proportional to the severity of PTSD symptoms. Yehuda (54) also has reported the results of an unpublished study by Heidi Resnick, in which acute cortisol response to trauma was studied from blood samples from 20 acute rape victims. Three months later, a prior trauma history was taken, and the subjects were evaluated for the presence of PTSD. Victims with a prior history of sexual abuse were significantly more likely to have developed PTSD three months following the rape than rape victims who did not develop PTSD. Cortisol levels shortly after the rape were correlated with histories of prior assaults: the mean initial cortisol level of individuals with a prior assault history was 15 ug/dl compared to 30 ug/dl in individuals without. These findings can be interpreted to mean either that prior exposure to traumatic events result in a blunted cortisol response to subsequent trauma, or in a quicker return of cortisol to baseline following stress. The fact that Yehuda et al (45) also found subjects with PTSD to be hyperresponsive to low doses of dexamethasone argues for an enhanced sensitivity of the HPA feedback in traumatized patients.

3) Serotonin. While the role of serotonin in PTSD has not been systematically investigated, both the fact that inescapably shocked animals develop decreased CNS serotonin levels (55), and that serotonin re-uptake blockers are effective pharmacological agents in the treatment of PTSD, justify a brief consideration of the potential role of this neurotransmitter in PTSD. Decreased serotonin in humans has repeatedly been correlated with impulsivity and aggression (56,57,58). The literature tends to readily assume that these relationships are based on genetic traits. However, studies of impulsive, aggressive and suicidal patients seem to find at least as robust an association between those behaviors and histories of childhood trauma (e.g. 59,60,61). It is likely that both temperament and experience affect relative CNS serotonin levels (12).

Low serotonin in animals is also related to an inability to modulate arousal, as exemplified by an exaggerated startle (62,63), and increased arousal in response to novel stimuli, handling, or pain (63). The behavioral effects of serotonin depletion on animals is characterized by hyperirritability, hyperexitability, and hypersensitivity, and an "...exaggerated emotional arousal and/or aggressive display, to relatively mild stimuli" (63). These behaviors bear a striking resemblance to the phenomenology of PTSD in humans. Furthermore, serotonin re-uptake inhibitors have been found to be the most effective pharmacological treatment of both obsessive thinking in people with OCD (64), and of involuntary preoccupation with traumatic memories in people with PTSD (65,66). It is likely that serotonin plays a role in the capacity to monitor the environment flexibly and to respond with behaviors that are situation-appropriate, rather than reacting to internal stimuli that are irrelevant to current demands.

4). Endogenous opioids. Stress induced analgesia (SIA) has been described in experimental animals following a variety of inescapable stressors such as electric shock, fighting, starvation and cold water swim (67). In severely stressed animals, opiate withdrawal symptoms can be produced both by termination of the stressful stimulus or by naloxone injections. Stimulated by the findings that fear activates the secretion of endogenous opioid peptides, and that SIA can become conditioned to subsequent stressors and to previously neutral events associated with the noxious stimulus, we tested the hypothesis that in people with PTSD, re-exposure to a stimulus resembling the original trauma will cause an endogenous opioid response that can be indirectly measured as naloxone reversible analgesia (68,69). We found that two decades after the original trauma, people with PTSD developed opioid-mediated analgesia in response to a stimulus resembling the traumatic stressor, which we correlated with a secretion of endogenous opioids equivalent to 8 mg of morphine. Self-reports of emotional responses suggested that endogenous opioids were responsible for a relative blunting of the emotional response to the traumatic stimulus.
Endogenous Opiates & Stress Induced Analgesia: Possible Implications for Affective Function

When young animals are isolated, and older ones attacked, they respond initially with aggression (hyperarousal- fight- protest), and, if that does not produce the required results, with withdrawal (numbing-flight-despair). Fear-induced attack or protest patterns in the young serve to attract protection, and in mature animals to prevent or counteract the predator's activity. During external attacks pain-inhibition is a useful defensive capacity, because attention to pain would interfere with effective defense: grooming or licking wounds may attract opponents and stimulate further attack (70). Thus defensive and pain-motivated behaviors are mutually inhibitory. Stress-induced analgesia protects organisms against feeling pain while engaged in defensive activities. As early as 1946, Beecher (71), after observing that 75% of severely wounded soldiers on the Italian front did not request morphine, speculated that "strong emotions can block pain". Today, we can reasonably assume that this is due to the release of endogenous opioids(68,69).

Endogenous opioids, which inhibit pain and reduce panic, are secreted after prolonged exposure to severe stress. Siegfried et al (70) have observed that memory is impaired in animals when they can no longer actively influence the outcome of a threatening situation. They showed that both the freeze response and panic interfere with effective memory processing: excessive endogenous opioids and NE both interfere with the storage of experience in explicit memory. Freeze/numbing responses may serve the function of allowing organisms to not "consciously experience" or not to remember situations of overwhelming stress (and which thus will also keep them from learning from experience). We have proposed that the dissociative reactions in people in response to trauma may be analogous to this complex of behaviors that occur in animals after prolonged exposure to severe uncontrollable stress (68).
Developmental Level Affects the Psychobiological Effects of Trauma

While most studies on PTSD have been done on adults, particularly on war veterans, in recent years a small prospective literature is emerging that documents the differential effects of trauma at various age levels. Anxiety disorders, chronic hyperarousal, and behavioral disturbances have been regularly described in traumatized children (e.g.72,73,74). In addition to the reactions to discrete, one time, traumatic incidents documented in these studies, intrafamilial abuse is increasingly recognized to produce complex post-traumatic syndromes (75), which involve chronic affect dysregulation, destructive behavior against self and others, learning disablities, dissociative problems, somatization, and distortions in concepts about self and others (76,77). The Field Trials for DSM IV showed that these this conglomeration of symptoms tended to occur together and that the severity of this syndrome was proportional to the age of onset of the trauma and its duration (78).

While current research on traumatized children is outside the scope of this review, it is important to recognize that a range of neurobiological abnormalities are beginning to be identified in this population. Frank Putnam's prospective, but as yet unpublished, studies (personal communications, 1991,1992,1993) are showing major neuroendocrine disturbances in sexually abused girls compared with normals. Research on the psychobiology of childhood trauma can be profitably informed by the vast literature on the psychobiological effects of trauma and deprivation in non-human primates (12,79).
Trauma & Memory: The Flexibility of Memory & the Engraving of Trauma

One hundred years ago, Pierre Janet (1) suggested that the most fundamental of mental activities is the storage and categorization of incoming sensations into memory, and the retrieval of those memories under appropriate circumstances. He, like contemporary memory researchers, understood that what is now called semantic, or declarative, memory is an active and constructive process and that remembering depends on existing mental schemata (3,80): once an event or a particular bit of information is integrated into existing mental schemes, it will no longer be accessible as a separate, immutable entity, but be distorted both by prior experience, and by the emotional state at the time of recall(3). PTSD, by definition, is accompanied by memory disturbances, consisting of both hypermnesias and amnesias (9,10). Research into the nature of traumatic memories (3) indicates that trauma interferes with delarative memory, i.e. conscious recall of experience, but does not inhibit implicit, or non-declarative memory, the memory system that controls conditioned emotional responses, skills and habits, and sensorimotor sensations related to experience. There now is enough information available about the biology of memory storage and retrieval to start building coherent hypotheses regarding the underlying psychobiological processes involved in these memory disturbances (3,16,17,25).

In the beginning of this century Janet already noted that: "certain happenings ... leave indelible and distressing memories-- memories to which the sufferer continually returns, and by which he is tormented by day and by night" (81). Clinicians and researchers dealing with traumatized patients have repeatedly made the observation that the sensory experiences and visual images related to the trauma seem not to fade over time, and appear to be less subject to distortion than ordinary experiences (1,49,82). When people are traumatized, they are said to experience "speechless terror": the emotional impact of the event may interfere with the capacity to capture the experience in words or symbols. Piaget (83) thought that under such circumstances, failure of semantic memory leads to the organization of memory on a somatosensory or iconic level (such as somatic sensations, behavioral enactments, nightmares and flashbacks). He pointed out: "It is precisely because there is no immediate accommodation that there is complete dissociation of the inner activity from the external world. As the external world is solely represented by images, it is assimilated without resistance (i.e. unattached to other memories) to the unconscious ego".
Traumatic memories are state dependent.

Research has shown that, under ordinary conditions, many traumatized people, including rape victims (84), battered women (85) and abused children (86) have a fairly good psychosocial adjustment. However, they do not respond to stress the way other people do. Under pressure, they may feel, or act as if they were traumatized all over again. Thus, high states of arousal seem to selectively promote retrieval of traumatic memories, sensory information, or behaviors associated with prior traumatic experiences (9,10). The tendency of traumatized organisms to revert to irrelevant emergency behaviors in response to minor stress has been well documented in animals, as well. Studies at the Wisconsin primate laboratory have shown that rhesus monkeys with histories of severe early maternal deprivation display marked withdrawal or aggression in response to emotional or physical stimuli (such as exposure to loud noises, or the administration of amphetamines), even after a long period of good social adjustment (87). In experiments with mice, Mitchell and his colleagues (88) found that the relative degree of arousal interacts with prior exposure to high stress to determine how an animal will react to novel stimuli. In a state of low arousal, animals tend to be curious and seek novelty. During high arousal, they are frightened, avoid novelty, and perseverate in familiar behavior, regardless of the outcome. Under ordinary circumstances, an animal will choose the most pleasant of two alternatives. When hyperaroused, it will seek whatever is familiar, regardless of the intrinsic rewards. Thus, animals who have been locked in a box in which they were exposed to electric shocks and then released return to those boxes when they are subsequently stressed. Mitchell concluded that this perseveration is nonassociative, i.e. uncoupled from the usual reward systems.

In people, analogous phenomena have been documented: memories (somatic or symbolic) related to the trauma are elicited by heightened arousal (89). Information acquired in an aroused, or otherwise altered state of mind is retrieved more readily when people are brought back to that particular state of mind (90,91). State dependent memory retrieval may also be involved in dissociative phenomena in which traumatized persons may be wholly or partially amnestic for memories or behaviors enacted while in altered states of mind (2,3,92).

Contemporary biological researchers have shown that medications that stimulate autonomic arousal may precipitate visual images and affect states associated with prior traumatic experiences in people with PTSD, but not in controls. In patients with PTSD the injection of drugs such as lactate (93) and yohimbine (52) tends to precipitate panic attacks, flashbacks (exact reliving experiences) of earlier trauma, or both. In our own laboratory, approximately 20% of PTSD subjects responded with a flashback of a traumatic experience when they were presented with acoustic startle stimuli.
Trauma, neurohormones and memory consolidation.

When people are under severe stress, they secrete endogenous stress hormones that affect the strength of memory consolidation. Based on animal models it has been widely assumed (3,46,94) that massive secretion of neurohormones at the time of the trauma plays a role in the long term potentiation (LTP) (and thus, the over- consolidation) of traumatic memories. Mammals seem equipped with memory storage mechanisms that ordinarily modulate the strength of memory consolidation according to the strength of the accompanying hormonal stimulation (95,96). This capacity helps the organism evaluate the importance of subsequent sensory input according to the relative strength of associated memory traces. This phenomenon appears to be largely mediated by NE input to the amygdala (97,98, figure 2). In traumatized organisms, the capacity to access relevant memories appears to have gone awry: they become overconditioned to access memory traces of the trauma and to "remember" the trauma whenever aroused. While norepinephrine (NE) seems to be the principal hormone involved in producing LTP, other neurohormones secreted under particular stressful circumstances, such as endorphins and oxytocin, actually inhibit memory consolidation (99).

The role of NE in memory consolidation has been shown to have an inverted U-shaped function (95,96): both very low and very high levels of CNS NE activity interfere with memory storage. Excessive NE release at the time of the trauma, as well as the release of other neurohormones, such as endogenous opioids, oxytocin and vasopressin, are likely to play a role in creating the hypermnesias and the amnesias that are a quintessential part of PTSD (9,10). It is of interest that childbirth, which can be extraordinarily stressful, almost never seems to result in post traumatic problems (100). Oxytocin may play a protective role that prevents the overconsolidation of memories surrounding childbirth.

Physiological arousal in general can trigger trauma-related memories, while, conversely, trauma-related memories precipitate generalized physiological arousal. It is likely that the frequent re-living of a traumatic event in flashbacks or nightmares cause a re-release of stress hormones which further kindle the strength of the memory trace (46). Such a positive feedback loop could cause subclinical PTSD to escalate into clinical PTSD (16), in which the strength of the memories appear so deeply engraved that Pitman and Orr (17) have called it "the Black Hole" in the mental life of the PTSD patient, that attracts all associations to it, and saps current life of its significance.
Memory, Trauma & the Limbic System

The limbic system is thought to be the part of the CNS that maintains and guides the emotions and behavior necessary for self-preservation and survival of the species (101), and that is critically involved in the storage and retrieval of memory. During both waking and sleeping states signals from the sensory organs continuously travel to the thalamus whence they are distributed to the cortex (setting up a "stream of thought"), to the basal ganglia (setting up a "stream of movement") and to the limbic system where they set up a "stream of emotions"(102), that determine the emotional significance of the sensory input. It appears that most processing of sensory input occurs outside of conscious awareness, and only novel, significant or threatening information is selectively passed on to the neocortex for further attention. Since people with PTSD appear to over-interpret sensory input as a recurrence of past trauma and since recent studies have suggested limbic system abnormalities in brain imaging studies of traumatized patients (103,104), a review of the psychobiology of trauma would be incomplete without considering the role of the limbic system in PTSD (also see 105). Two particular areas of the limbic system have been implicated in the processing of emotionally charged memories: the amygdala and the hippocampus (Table 2).

The amygdala. Of all areas in the CNS, the amygdala is most clearly implicated in the evaluation of the emotional meaning of incoming stimuli (106). Several investigators have proposed that the amygdala assigns free-floating feelings of significance to sensory input, which the neocortex then further elaborates and imbues with personal meaning (101,106,107,108). Moreover, it is thought to integrate internal representations of the external world in the form of memory images with emotional experiences associated with those memories (80). After assigning meaning to sensory information, the amygdala guides emotional behavior by projections to the hypothalamus, hippocampus and basal forebrain (106,107,109).

The septo-hippocampal system, which anatomically is adjacent to the amygdala, is thought to record in memory the spatial and temporal dimensions of experience and to play an important role in the categorization and storage of incoming stimuli in memory. Proper functioning of the hippocampus is necessary for explicit or declarative memory (109). The hippocampus is thought to be involved in the evaluation of spatially and temporally unrelated events, comparing them with previously stored information and determining whether and how they are associated with each other, with reward, punishment, novelty or non-reward (107,110). The hippocampus is also implicated in playing a role in the inhibition of exploratory behavior and in obsessional thinking, while hippocampal damage is associated with hyper-responsiveness to environmental stimuli (111,112).

The slow maturation of the hippocampus, which is not fully myelinated till after the third or fourth year of life, is seen as the cause of infantile amnesia (113,114). In contrast, it is thought that the memory system that subserves the affective quality of experience (roughly speaking procedural, or "taxon" memory) matures earlier and is less subject to disruption by stress (112).

As the CNS matures, memory storage shifts from primarily sensorimotor (motoric action) and perceptual representations (iconic), to symbolic and linguistic modes of organization of mental experience (83). With maturation, there is an increasing ability to categorize experience, and link it with existing mental schemes. However, even as the organism matures, this capacity, and with it, the hippocampal localization system, remains vulnerable to disruption (45,107,110,115,116). A variety of external and internal stimuli, such as stress induced corticosterone production (117), decreases hippocampal activity. However, even when stress interferes with hippocampally mediated memory storage and categorization, it is likely that some mental representation of the experience is laid down by means of a system that records affective experience, but that has no capacity for symbolic processing and placement in space and time (figure 2).

Decreased hippocampal functioning causes behavioral disinhibition, possibly by stimulating incoming stimuli to be interpreted in the direction of "emergency" (fight/flight) responses. The neurotransmitter serotonin plays a crucial role in the capacity of the septo-hippocampal system to activate inhibitory pathways that prevent the initiation of emergency responses until it is clear that they will be of use (110). This observation made us very interested in a possible role for serotonergic agents in the treatment of PTSD.
"Emotional memories are forever"

In animals, high level stimulation of the amygdala interferes with hippocampal functioning (107, 109). This implies that intense affect may inhibit proper evaluation and categorization of experience. In mature animals one-time intense stimulation of the amygdala will produce lasting changes in neuronal excitability and enduring behavioral changes in the direction of either fight or flight (118). In kindling experiments with animals, Adamec et al (119) have shown that, following growth in amplitude of amygdala and hippocampal seizure activity, permanent changes in limbic physiology cause a lasting changes in defensiveness and in predatory aggression. Pre-existing "personality" played a significant role in the behavioral effects of amygdala stimulation in cats: animals that are temperamentally insensitive to threat and prone to attack tend become more aggressive, while in highly defensive animals different pathways were activated, increasing behavioral inhibition (119).

In a series of experiments, LeDoux has utilized repeated electrical stimulation of the amygdala to produce conditioned fear responses. He found that cortical lesions prevent their extinction. This led him to conclude that, once formed, the subcortical traces of the conditioned fear response are indelible, and that "emotional memory may be forever" (118). In 1987, Lawrence Kolb (29) postulated that patients with PTSD suffer from impaired cortical control over subcortical areas responsible for learning, habituation, and stimulus discrimination. The concept of indelible subcortical emotional responses, held in check to varying degrees by cortical and septo-hippocampal activity, has led to the speculation that delayed onset PTSD may be the expression of subcortically mediated emotional responses that escape cortical, and possibly hippocampal, inhibitory control (3,16,94,120,121).

Decreased inhibitory control may occur under a variety of circumstances: under the influence of drugs and alcohol, during sleep (as nightmares), with aging, and after exposure to strong reminders of the traumatic past. It is conceivable that traumatic memories then could emerge, not in the distorted fashion of ordinary recall, but as affect states, somatic sensations or as visual images (nightmares [81] or flashbacks [52]) that are timeless and unmodified by further experience.
Psychopharmacological Treatment

The goal of treatment of PTSD is to help people live in the present, without feeling or behaving according to irrelevant demands belonging to the past. Psychologically, this means that traumatic experiences need to be located in time and place and distinguished from current reality. However, hyperarousal, intrusive reliving, numbing and dissociation get in the way of separating current reality from past trauma. Hence, medications that affect these PTSD symptoms are often essential for patients to begin to achieve a sense of safety and perspective from which to approach their tasks. While numerous articles have been written about the drug treatment of PTSD, to date, only 134 people with PTSD have been enrolledin published double blind studies. Most of these have been Vietnamcombat veterans. Unfortunately, up until recently, only medications which seem to be of limited therapeutic usefulness have beenthesubject of adequate scientific scrutiny. While the only published double blind studies of medications in the treatment of PTSDhave been tricyclic antidepressants and MAO Inhibitors (122,123,124), it is sometimes assumed that they therefore also are themosteffective. Three double-blind trials of tricyclic antidepressants have been published (122,124,125), two of which demonstrated modest improvement in PTSD symptoms. While positive resultshave been claimed for numerous other medications in case reportsand open studies, at the present time there are no data aboutwhich patient and which PTSD symptom will predictably respond toanyof them. Success has been claimed for just about every class ofpsychoactive medication, including benzodiazepines (127), tricyclic antidepressants (122,125), monamine oxidase inhibitors (122,129) lithium carbonate (127), beta adrenergic blockers and clonidine (130), carbamezapine (131) and antipsychotic agents. The accumulated clinical experience seems to indicate that understanding thebasic neurobiology of arousal and appraisal is the most useful guideinselecting medications for people with PTSD (124,125). Autonomic arousal can be reduced at different levels in the CNS: throughinhibition of locus coeruleus noradrenergic activity with clonidine and the beta adrenergic blockers (130,132), or by increasing the inhibitory effect of the gaba-ergic system with gaba- ergicagonists (the benzodiazepines). During the past two years a numberof case reports and open clinical trials of fluoxetine were followedby our double blind study of 64 PTSD subjects with fluoxetine (65). Unlike the tricyclic antidepressants, which were effective on either the intrusive (imipramine) or numbing (amitryptiline) symptoms of PTSD, fluoxetine proved to be effective forthewhole spectrum of PTSD symptoms. It also acted more rapidly thanthetricyclics. The fact that fluoxetine has proven to be such aneffective treatment for PTSD supports a larger role of the serotonergic system in PTSD (66). Rorschach tests adminstered by blindscorers revealed that subjects on fluoxetine became able to takedistance from the emotional impact of incoming stimuli and to becomeable to utilize cognition to harness the emotional responses tounstructured visual stimuli (van der Kolk et al, unpublished).

While the subjects improved clinically, their startle habituation got worse (van der Kolk et al, unpublished). The 5-HT1a agonist buspirone shows some promise in facilitating habituation (133) and thus may play a useful adjunctive role in the pharmaco- therapy of PTSD. Even newer research has suggested abnormalities of the N-methyl-D-aspartate (NMDA) receptor and of glutamate in PTSD (134), opening up potential new avenues for the psychopharmacological treatment of PTSD.

Labels: , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: "Afibbers" pdf file of discussion about minerals DATE: 10/01/2007 07:24:00 AM ----- BODY:
Can You Hang on to Magnesium? For magnesium to get into cells it requires thiamine (vitamin B1). Try thiamine 100mgs daily – if you are already taking some in a multivitamin preparation, then take the B1 at 100mg a day. For magnesium to be retained inside cells you need good antioxidant status. Selenium is the main mineral antioxidant. Food tables are unreliable because food content is dependent on soil levels of selenium. Assuming good soil levels, (which is a big assumption), foods rich in selenium include wholegrains, organ meats, butter, garlic and onion. Seafoods are rich in selenium and obviously not dependent on soil levels. Boron is necessary for normal calcium and magnesium metabolism. I also find boron very useful for arthritis, perhaps because of its effect on calcium and magnesium. For arthritis you need 9mgs a day for 3 months, then reduce to a maintenance dose of 3-6mgs daily. At present the only way I know how to ascertain whether or not magnesium levels are replete is to measure a red cell magnesium. http://www.immunesupport.com/library/showarticle.cfm/id/2892 Richard Boron may not be advantageous for Mg. as stated above, or the site above could be altogether wrong. Boron and its involvement with attention deficit disorder is a concept that appears not to have been considered before. Boron, phenols and/or histamine may possibly cause thinning of the middle part of the brain where nerve fibres cross over. This part of the brain is called the corpus callosum. Damage to this area (prior to birth) causes learning disabilities. Boron increases copper in the body. High copper levels cause reductions in thiamine (vitamin B1). Lack of thiamine causes many problems associated with ADD. A lack of this vitamin reduces oxygen supply to the brain. Low cholinesterase levels are associated with a thiamine deficiency. Lack of thiamine may indirectly lower the neurotransmitter dopamine. There are below normal dopamine levels in hyperactive children. Low cholinesterase levels are sometimes associated with asthma. Boron interferes with the metabolism of phenols. Phenylalanine (a phenol) is able to reduce serotonin levels. Serotonin levels are reduced in children with ADD. The medication Ritalin used in the treatment of ADD inhibits the metabolism of coumarins (phenols). Low and high histamine levels are also discussed. Boron reduces pyridoxine (vitamin B6) levels in the body. The importance of this occurrence to the reduction of the symptoms of ADD is covered throughout the book. A brief description of how boron interacts with body nutrients is discussed. Boron has the ability to cause an excess or depletion of vital substances. This causes a spin off in alteration of other nutrients. For example, boron has an indirect effect of reducing zinc levels in the body. Boron increases calcium retention in the body. Calcium reduces zinc. As outlined in this book, boron plays a role in excreting pyridoxine (vitamin B6) from the body. Vitamin B6 is necessary for zinc absorption. Vitamin B6 and zinc play major roles in neurotransmitter function. Neurotransmitters are chemicals that relay messages between nerves in the body. Some neurotransmitters have a relaxing effect whilst others have a stimulatory effect. An imbalance of neurotransmitters (as discussed throughout this book) may cause symptoms of ADHD/ADD. Nausea during pregnancy is associated with a deficiency of vitamin B6 (pyridoxine) and zinc. Acute toxicity of boron presents with nausea, vomiting, lethargy, dermatitis and diarrhoea. ADD is possibly linked to the food the mother consumed during pregnancy. A diet (during pregnancy) giving a high intake of boron containing foods together with a high intake of calcium containing foods may be a contributing factor to the ADD symptoms of the child. Water supplies containing high levels of calcium and/or copper reduce zinc absorption in the body. Boron is found in apples, pears, grapes, nuts, leafy green vegetables and legumes. My levels of copper were high, and zinc was low. My hair analysis of Boron was fairly normal, but just a tad to the low side. Hmmmmm????? So is my problem more that I need B1 to absorb the Mg. Questions to ask Dr. Gersten.

Labels: , , , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: EFAs and behavior DATE: 9/08/2007 07:08:00 AM ----- BODY:
What are EFAs? · Nutrition: Essential Fatty Acids (EFAs): What are EFAs? Things to Avoid · Nutrition: Essential Fatty Acids (EFAs): Things to Avoid Omega-3 Deficiency Symptoms List of Symptoms "These signs include · dry hair, · dry skin (often noticed as a 'goosebump' rash on the upper arms and/or upper thighs), · excessive thirst, · frequent urination, · problems with attention and so on." ILT: Essential Fatty Acids (EFAs) Keratosis Pilaris Keratosis Pilaris: Definition "Keratosis pilaris is a common skin condition that looks like small goose bumps, which are actually dead skin cells that build up around the hair follicle." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Description · "Keratosis pilaris is a disorder that occurs around the hair follicles of the upper arms, thighs, and sometimes the buttocks. · It presents as small, benign bumps or papules that are actually waxy build-ups of keratin. Normally skin sloughs off. However, around the hair follicle where the papules form, the keratinized skin cells slough off at a slower rate, clogging the follicles. · This is generally thought to be genetic disorder, although the symptoms of keratosis pilaris are often seen with ichthyosis and allergic dermatitis. It can also be observed in people of all ages who have either inherited it or have a vitamin A deficiency or have dry skin. · Keratosis pilaris is a self-limiting disorder that disappears as the person ages. · It can become more severe when conditions are dry such as during the winter months or in dry climates." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Causes and Symptoms "The specific causes of this disorder are unknown. Since this disorder runs in families, it is thought to be hereditary. Keratosis pilaris is not a serious disorder and is not contagious. The symptoms of keratosis pilaris are based on the development of small white papules the size of a grain of sand on the upper arms, thighs, and occasionally the buttocks and face. The papules occur around a hair follicle and are firm and white. They feel a little like coarse sandpaper, but they are not painful and there usually is no itching associated with them. They are easily removed and the material inside the papule usually contains a small, coiled hair." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Treatment · "To treat keratosis pilaris patients can try several strategies to lessen the bumps. · First, the patient can supplement the natural removal of dry skin and papules by using a loofah or another type of scrub showering or bathing. · A variety of different over-the-counter (OTC) lotions, ointments, and creams can also be applied after showering while the skin is still moist and then several times a day to keep the area moist. · Medicated lotions with urea, 15% alphahydroxy acids, or Retin A can also be prescribed by the dermatologist and applied one to two times daily. · Systemic (oral) medications are not prescribed for keratosis pilaris. · However if papules are opened and become infected, antibiotics may be necessary to treat the infection." HealthAtoZ.com: Keratosis Pilaris "I did a little research on vitamin a deficiency and it seems to be, if not a cause, then a trigger to a lot of skin problems. However, taking vitamin A does not necessarily eliminate the deficiency. I know this because I was taking a vitamin A/B combo and nothing was happening. Then after doing some reading about eczema…omega 3 fatty acids (found in cod liver oil supplements [caution: cod liver oil in the quantity necessary to get three grams per day of omega-3's would contain dangerous levels of vitamin A]) help the body absorb vitamin A. This has worked for me and has offset a lot of the uncomfortable dry skin associated with not only my eczema, but also on my arms and legs (KP)." KeratosisPilaris.org: Archives: Re: Vitamin A and KP · Essential Fatty Acids (EFAs): Things to Avoid: Too Much Fish, Farm-Raised Fish · Essential Fatty Acids (EFAs): Things to Avoid: Dangerous Levels of Vitamin A · Nutrition: Vitamins and Minerals: Liquid Multivitamins: Absorption · Nutrition: Vitamins and Minerals: Vitamin A: Absorption Effects ADD, Dyslexia "If a child does not get enough EFAs, the myelin sheath protecting the axons of billions of neurons may not be adequate. Recent research is showing that boys with ADD have EFA deficiencies (Stevens, L. et al, 1995:000-000) and similar deficiencies are possibly responsible for the symptoms of dyslexia. (Stordy & Nicholl, 2000:105)." ILT: Essential Fatty Acids (EFAs) Depression "When researchers monitor eating habits across countries, they find that as fish consumption goes up, depression rates go down. In fact, there is a sixty-fold difference in depression rates across countries from the highest (Japan and Taiwan) to the lowest (North America, Europe and New Zealand) omega-3 fat consumption. Even postpartum depression decreases as women increase their consumption of fish. Many people also report a drop in mood when they switch too quickly to a low-fat diet. (Page 156)" Book: Somer, Elizabeth, M.A., R.D. Food & Mood. Henry Holt and Company, LLC, 1999. Serotonin and Dopamine "Over the last decade, neuroscientists have been examining the consequences of omega-3 deficiencies in the central nervous system. Alterations in serotonin and dopamine levels, as well as the functioning of these two important neurotransmitters is evident in an omega-3 deficiency. The changes observed in omega-3 deficiency in animals is strikingly similar to that found in autopsy studies of human depression.20" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Blood-Brain Barrier "In addition to changing serotonin and dopamine levels and functioning, omega-3 deficiencies are known to compromise the blood-brain barrier, which normally protects the brain from unwanted matter gaining access.21" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Blood Flow "Omega-3 deficiency can also decrease normal blood flow to the brain,22,23 an interesting finding given the studies which show that patients with depression have compromised blood flow to a number of brain regions.24,25" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Antidepressant Activity "Finally, omega-3 deficiency also causes a 35 percent reduction in brain phosphatidylserine (PS) levels.26 This is also of relevance when considering that PS has documented antidepressant activity in humans.27,28" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Mechanisms of EPA/DHA Regulation of Mood "DHA [an omega-3 fatty acid] is found in high levels in the cells of the central nervous system (neurons); here it acts as a form of scaffolding for structural support.29 When omega-3 intake is inadequate, the nerve cell becomes stiff as cholesterol and omega-6 fatty acids are substituted for omega-3.30 When a nerve cell becomes rigid, proper neurotransmission from cell to cell and within cells will be compromised.31 While DHA provides structure and helps to ensure normal neurotransmission, EPA [an omega-3 fatty acid] may be more important in the signaling within nerve cells.32 Normalizing communications within nerve cells has been suggested to be an important factor in alleviating depressive symptoms.33" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "In addition, EPA can lower the levels of two important immune chemicals, · tumour necrosis factor alpha (TNFa) and · interleukin 1 beta (IL-1ß), · as well as prostaglandin E2.34 All three of these chemicals are elevated in depression.35-38 In fact, higher levels of TNFa and IL-1ß are associated with severity of depression.39" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "Finally, EPA has been hypothesized to increase brain-derived neurotropic factor (BDNF), which is known to be lower in depressed patients.20 BDNF is neuroprotective, enhances neurotransmission, has antidepressant activity and supports normal brain structure. BDNF may prevent the death of nerve cells in depression." New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Correcting an Omega-3 Deficiency Note: More information about sources of omega-3s can be found on the page Nutrition: Essential Fatty Acid (EFA) Sources Flax "Flax, our richest source of omega 3, quickly replenishes a long-standing omega 3 deficiency. A dozen 8 oz. bottles of good quality flax oil consumed over the course of a few months will suffice [approximately one bottle every five days, 1.6 ounces per day]." The Edelson Center: Essential Fatty Acids: The Healing Fats "There have been some published case reports indicating that flaxseed oil may be helpful in cases of bipolar depression and the anxiety disorder agoraphobia.40 The first controlled clinical trial indicating that omega-3 fatty acids may be of benefit in depression was published in 1999. In this case, 9:6 g ['9:6 g' should be read a dose of 6 g per day for a period of nine days?] of EPA/DHA versus placebo led to longer periods of remission and improvement in depressive symptoms in those with bipolar depression.41" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 2g Daily of Pure EPA "Some researchers theorize that such high doses of EPA/DHA may not be necessary and that low levels of pure EPA may be of benefit.32 In a study published in the American Journal of Psychiatry, researchers showed that just 2g of pure EPA could improve the symptoms of treatment-resistant depression. The researchers found that the EPA (versus placebo), when added to an ineffective antidepressant for one month, significantly improved depressive symptoms.42" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 1g Daily of Pure EPA "A larger study published in Archives of General Psychiatry replicated these findings, however, this time various doses of EPA were examined. Those on ineffective antidepressants were given 1g, 2g or 4g of pure EPA or a placebo in addition to the medication. Interestingly, the 1g daily dose of EPA led to the most significant improvements over the three-month study; it appeared that less was more. There were significant improvements in depressive symptoms, sleep, anxiety, lassitude, libido and thoughts of suicide.43" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "Harvard researchers have also shown that just 1g of pure EPA is beneficial in the treatment of borderline personality disorder. This personality disorder, which is particularly difficult to treat, is characterized by both depressive and aggressive symptoms. This was a two-month placebo-controlled study and the results showed that EPA has a mood-regulating effect, improving both depression and aggression versus placebo.46" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 4.4g EPA and 2.2g DHA Mix "Researchers from Taiwan Medical University published a recent study in which they found that a 4.4g EPA and 2.2g DHA mix could alleviate depression versus placebo in those with treatment-resistant depression. This was a two-month study involving patients who were on antidepressants that were not working. As with the other omega-3 studies discussed, the fish oil was well tolerated and no adverse events were reported.44" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Antarctic Krill Oil (400mg EPA, 240mg DHA) "There is also evidence that omega-3 oils may be of benefit in treating depressive symptoms outside of major depressive disorder. Canadian researchers showed that Antarctic krill oil (400mg EPA, 240mg DHA) could improve depressive symptoms associated with premenstrual syndrome.45" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH DHA Alone not Recommended "To date, with one exception, all studies conducted on omega-3 fatty acids and mood have had a positive outcome. The singular negative study examined pure DHA in patients with depression. The results in the case showed that DHA alone was no better than placebo in alleviating depressive symptoms.47" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Omega-6 Deficiency "Long--term exclusion or excessive use of flax oil can result in omega 6 deficiency after about two years, because flax oil is omega 3 rich but omega 6 poor." The Edelson Center: Essential Fatty Acids: The Healing Fats

Labels: , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Supplements for ADHD DATE: 8/30/2007 05:45:00 PM ----- BODY:
ADD & ADHD ADD & ADHD Natural Control of ADD & ADHD Billie J. Sahley, Ph.D., CNC In Toxic Psychiatry, Peter Breggin, MD states, Hyperactivity is the most frequent justification for drugging children. Difficult-to-control children are certainly not a new phenomenon, but attempts to give them a medical diagnosis are the product of modern psychology and psychiatry. At first, psychiatrists called hyperactivity a brain disease: minimal brain dysfunction (MBD). When no minimal brain dysfunction could be demonstrated, the label became attention deficit disorder (ADD). Six million children in this country suffer some type of learning disability, ADD, or ADD with hyperactivity (ADHD). Over two million children currently take Ritalin for ADD/ADHD. ADD and ADHD may be caused by psychological problems, including trauma and abuse, nutritional deficiencies, chemical imbalances, allergic responses to food and chemicals, or a poor diet. A failure in the brains inhibitory system (the ability of the brain to inhibit and control itself) may also cause ADD/ADHD. Ritalin, the most commonly used drug for ADD and ADHD, is an amphetamine and a Schedule II class drug (other Schedule II drugs are morphine, opium, and medicinal cocaine). Doctors prescribe Ritalin for many children who do not need it, causing a number of adverse mental and physical side effects. Yet this potent, toxic drug is being used as a quick fix to quiet children. Surprisingly, prescription rates for Ritalin doubled between 1992 and 1996. Children demonstrating symptoms of anxiety, ADHD or ADD often have an imbalance in their brains biochemistry. A biochemical imbalance results from a deficiency of neurotransmitters, the chemical messengers of the brain. If a biochemical imbalance goes untreated, a child can display maladaptive behavior, followed by possible long-term physical and emotional problems. A childs state of health reflects his or her state of nutrition. When minerals, vitamins, amino acids, enzymes, or even hormones are deficient in a childs system, the result can be a disturbed biochemical homeostasis causing impaired functions in the brain. This, in turn, can cause an inability to focus, concentrate, and stay on task. At the Pain and Stress Center in San Antonio, we have successfully treated numerous children with orthomolecular therapy. Orthomolecular therapy corrects the brains biochemical imbalance, without toxic drugs that can produce adverse side effects. ADD/ADHD presents a major problem facing parents today. Most people think of hyperactivity as some type of behavioral problem (a child who is impatient, impulsive, and constantly moving); but not all hyperactive children are aggressive. Some are very passive, withdrawn, and find it hard to communicate their feelings. ADD/ADHD is not a condition that can be measured in precise scientific terms. Nor is it a situation with a quick fix, especially with powerful and addictive drugs such as Ritalin. ADD/ADHD is a complex and intricate condition in which children demonstrate maladaptive or disorganized behaviors, which put them out of sync with the world around them. Numerous clinical studies established that hyperactive children often have low serotonin levels. A proper combination of tryptophan or 5-HTP and B6, elevates the serotonin level and balances the brain; the childs symptoms diminish. The dosage, of course, depends on the childs age, weight, and the degree of hyperactivity. Effectiveness of Amino Acids Neurotransmitters affect behavior and learning. A neurotransmitter deficiency consequently has a dramatic effect on childrens or adults abilities to learn and function in an orderly manner. Most hyperactive and ADD children are born with a shortage of neurotransmitters, establishing a genetic link, most often on the male side. These children also do not manufacture the needed amount of these chemical messengers. Where do we get neurotransmitters? From the amino acids, GABA, glycine, taurine, tyrosine, glutamine and tryptophan. Do children or adults get enough aminos through diet? NO! Balanced amino-acid doses, in the right combination and formulas, produce the needed neurotransmitters naturally. Using a stimulant medication to try to produce neurotransmitters is like a shotgun going off in the childs brain. Our children were not born with Ritalin in their brain, so how can they have a Ritalin deficiency? Approximately fifty different neurotransmitters exist in the human brain, but communication between brain cells uses only ten (approximately) major neurotransmitters. How we feed the brain directly affects our production of neurotransmitters. With proper nutrition and supplementation, we can correct or enhance mind, mood, memory, and behavior. All major neurotransmitters are made from amino acids and dietary protein. One of the dangers of a low-protein diet is not ingesting enough amino acids to make adequate brain neurotransmitters. Apathy, lethargy, difficulty concentrating, loss of interest, and insomnia all result when the diet does not include adequate amounts of amino acids. Drugs do not produce or increase production of neurotransmitters. Drugs only address symptoms. Amino acids restore the balance nature intended. Some of the major symptoms of neurotransmitter deficiencies are ADD, ADHD, brain fog, mood swings, increased stress, anxiety, depression, insomnia, irritability, and aggression. Stress plays a major role in the depletion of neurotransmitters. Inhibitory neurotransmitters are the keys to behavior, emotions, and pain. Inhibitory amino acids include tryptophan, taurine, GABA, and glycine. Millions of people have turned to drugs known as SSRIs (Selective Serotonin Reuptake Inhibitors). These drugs, such as Prozac, Paxil, Zoloft, and Effexor work by selective enhancement of serotonin levels. SSRIs prevent the presynaptic nerve from reabsorbing serotonin that it previously secreted. Prozac causes an increase in brain serotonin levels; but Prozac and other prescription drugs do not increase neurotransmitters. (See Figure 1). 5-HTP is synergistic with other supplements that enhance neurotransmitters such as GABA, glutamine, tyrosine, phenylalanine, and glycine. Magnesium prolongs the benefits of 5-HTP. Chronic stress depletes available serotonin, as well as interferes with serotonins ability to control behavior. Research demonstrates that low serotonin levels can change brain function and impair learning. Low serotonin may be responsible for an increase in depression and drug use among teens and children. Most teens with low serotonin levels are more prone to try recreational drugs or even prescription drugs, for relief. A low brain serotonin level impairs the ability to focus and reason. 5-HTP shows a lot of promise as a natural answer to a multitude of problems that plague adults and children. Use caution with 5-HTP if your child is taking prescription antidepressant medications. GABA (Gamma-aminobutyric acid) GABA, an inhibitory neurotransmitter, is found throughout the central nervous system. GABA assumes an ever-enlarging role as a significant influence on ADD, ADHD, stress, anxiety, and depression, as well as stress-induced illnesses. According to Candace Pert, a neuroscientist who discovered the GABA receptor, every cell in the body has a GABA receptor, which is one reason why GABA has such positive effects. GABA inhibits the cells from firing, diminishing anxiety-related messages. Tranquilizers provide only temporary relief. We have seen many patients on Xanax that still experience anxiety. They have been told it is not addictive: it is! THERE IS NO SUCH THING AS A TRANQUILIZER DEFICIENCY! Nutrient deficiencies do occur, however; and they can and do change behavior. GABA, glutamine, and glycine prove vital for energy and the smooth running of brain functions. We have successfully used these three amino acids with patients to ease anxiety, irritability, and ADD. Research demonstrates a large number of children who display ADD/ADHD behavior actually experience anxiety. If they use all available GABA, then the receptors in the brain become empty, allowing the brain to be bombarded with random firings of excitatory messages. However, when adequate amounts of GABA are present, the reception of multiple random firings are blocked, so the brain does not become overwhelmed. At the Pain & Stress Center we regularly combine GABA and other amino acids to achieve positive results. Dose amounts vary, depending on the age and weight of the child. GABA now takes its place as a major influence on those taking drugs, and in many cases, replacing the drugs. We have found that, when combined with other amino acids, GABA works exceptionally well with ADD children. L-Glutamine Glutamine, along with GABA and Glycine, is rapidly becoming an important therapeutic amino acid of the 21st century. Glutamine, found in many foods, is the third most abundant amino acid in the blood and brain. It also provides a major alternative fuel source for the brain when blood sugar levels are low. Glutamine functions as an inhibitory neurotransmitter, and is the precursor for GABA, the antianxiety amino acid. The amino acid trio of Glutamine, GABA, and Glycine plus B6 are among the major inhibitory neurotransmitters in the brain. Glutamine is found in the nerves of the hippocampus, the memory center of the brain, in the cranial nerves, and in many other areas of the brain. These three amino acids work together as inhibitory neurotransmitters. Anyone taking amino acids must take B6 to metabolize the amino acids. Intellectually impaired children and adults often show an increase in IQ after taking glutamine in combination with Ginkgo biloba and B6. Dr. Roger Williams demonstrated that children and adults diagnosed with ADHD showed a marked improvement when taking 250 mg to 1,000 mg of glutamine daily. GABA and glutamine are not only found in the brain, but also in the receptor sites throughout the body. Glutamine is the memory and concentration amino acid. Seventy five percent of hyperactive and ADD childrens blood tests showed low levels of glutamine. Dr. C. Fredericks research also demonstrated a definite increase in the IQs of children given glutamine. When glutamine was given daily, children showed impressive improvements in their abilities to learn, to retain, and to recall. Glutamine is a major part of my orthomolecular program for hyperactive and ADHD children. Glutamine is one of the amino acids that create the neurotransmitters in the brain that enhance learning and memory. Hyperactive and ADD children have low neurotransmitter levels, especially glutamine. Adding glutamine increases the level of neurotransmitters. Start with 500 mg of glutamine and gradually increase until you reach the optimal dose for your child, to a maximum of 3,000 mg per day. Taurine Taurine is now classified as a conditionally essential amino acid in the adult. In infants and children, however, taurine is an essential amino acid. As one of the sulfur amino acids, adults synthesize taurine from cysteine and methionine, provided B6 and zinc are present. Taurine is found abundantly throughout the body in the heart, olfactory bulb, central nervous system, and brain (hippocampus and pineal gland). As an inhibitory neurotransmitter, taurine, after GABA, is the second-most important inhibitory transmitter in the brain. Taurines inhibitory action in the brain equals that of GABA and glycine. Its inhibitory effect is one source of taurines anticonvulsant and antianxiety properties. Some children with Downs syndrome have shown an increase in IQ levels when taurine was added to their diet along with glutamine, B6, and vitamin E. The need for taurine increases whenever you experience more stress than usual, or have an illness. Tyrosine Tyrosine is the amino acid and inhibitory neurotransmitter that often helps overcome depression. Clinical studies show that tyrosine controls medication-resistant depression. In a 1980 issue of the American Journal of Psychiatry, a study by Dr. Alan Gelenberg of Harvard Medical School discussed the role of tyrosine in the control of anxiety and depression. Dr. Gelenberg postulated that the lack of available tyrosine results in deficiency of the hormone norepinephrine at a specific location in the brain that relates to mood problems such as depression. Children given tyrosine supplementation demonstrated a marked improvement in mental performance and mood stability. Tyrosine, because of its role in assisting the body to cope physiologically with stress and building the bodys natural store of adrenaline, deserves to be called the stress amino acid. Stress exhaustion requires tyrosine. During periods of stress, in order to continue coping with stress physiologically, the brain requires tyrosine. Tyrosine aids children and young teens, as well as adults, with recurrent depression and mood disorders. In children, dosage ranges from 200 to 500 mg daily. Glycine Glycine is a nonessential amino acid, with the simplest structure of all the amino acids resembling glucose (blood sugar) and glycogen (excess sugar converted in the liver for storage). Glycine is sweet to the taste, can be used as a sweetener, and can mask bitterness and saltiness. Pure glycine dissolves readily in water. As the third major inhibitory neurotransmitter in the brain, glycine readily passes the blood-brain barrier. Studies by the late Carl Pfeiffer, MD, Ph.D., demonstrated glycine as an important factor in psychiatric disorders. Glycine decreases the craving for sugar, and, in many cases, can replace sugar on foods such as cereal. Glycine calms aggression in both children and adults. When combined with GABA and glutamine, glycine influences brain function by slowing down anxiety-related messages from the limbic system. As a very nontoxic amino acid, both children and adults can use glycine. Glycine can be mixed with other amino acids. Doses for a child range between 500 to 2,000 mg daily, divided. Magnesium Hyperactive or ADD children are almost always deficient in magnesium. Magnesium proves necessary for proper brain energy and is the first mineral depleted when anyone (child or adult) is under stress. Magnesium is a stress mineral, and deficiency can lead to hyperactive or ADD behavior. Magnesium plays a significant role in sugar metabolism and in the proper utilization of carbohydrates to create energy. Magnesium is so very important in a childs diet, especially if he displays hyperactive behavior, ADD, or other behavioral problems. Magnesium can be taken in liquid form, tablet, or capsule. When added to the ADD/ADHD diet, calming effects sometimes occur immediately. Most magnesium exists inside the cells where it activates enzymes necessary for the metabolism of carbohydrates and amino acids. In 1988, a study published in Alternative Medicine Review linked the development of ADHD to low blood-serum magnesium levels. A group of children followed for six months were given 200 mg of magnesium a day. Researchers noted remarkably decreased hyperactivity in the children. As a major nutrient needed by ADD/ADHD children and adults, magnesium is the number one stress mineral needed by the body. Magnesium is responsible for over three hundred enzyme functions. It cannot be stored by the body, and it must be taken daily. Symptoms of magnesium deficiency include asthma, migraines, eye twitches, anxiety, confusion, muscle spasms, irritability, depression, nervousness, fatigue, mood swings, PMS, hypertension, and insomnia. Calcium A calcium deficiency can also induce ADD/ADHD behavior. A child deficient in calcium exhibits irritability, sleep disturbances, anger, and inattentiveness. The first signs of a calcium deficiency include nervous stomach, cramps, tingling in the arms and legs, and painful joints. A calcium deficiency can also lead to ADD/ADHD behavior. Children sensitive to dairy products must receive daily calcium supplementation in capsule, chewable, or liquid form. Children up to 10 years of age need 1000 mg of calcium daily; adolescents need 1,200 to 1,500 mg daily. For those involved in sports activities, calcium supplementation is a must. Huperzine Recent research reports that Huperzine A improves mental function and learning in adolescents. Chinese researchers designed a study to determine the efficiency of Huperzine on memory and learning. The clinical study included 34 matched pairs of junior middle school students that had significant complaints of poor memory and difficulty in learning. In the double blind trial, half of the students received a placebo while the other half received Huperzine A for four weeks. Academic performance was measured before and after the clinical trial. The Huperzine group scored significantly better on standard memory tests without side effects. Huperzine A is an extract derived from Chinese club moss. Huperzine can be combined with amino acids and other nutrients. The suggested dosage is one 50 mcg capsule in the morning and in the evening for children aged 12 and over. This information is excerpted from my book Control Hyperactivity/ADD Naturally. Other resources include Is Ritalin Necessary? Both are available through: Pain & Stress Center 5282 Medical Dr. #160 San Antonio, TX 78229-6023

Labels: , , , , , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Testosterone, Aggression, Serotonin DATE: 8/28/2007 03:42:00 PM ----- BODY:
Aggression: The Testosterone-Serotonin Link Forensic Psychiatric Division and 3Directorate, Be'er Yaakov Mental Health Center, Magen Prison, Ramleh, Israel 3Abarabnel Mental Health Center, Bat-Yam, Israel Both affiliated to Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel Key words: aggression, biological component, serotonin, testosterone Abstract The relevance of central neurotransmission to aggressive and impulsive behavior has become more evident due to extensive research in humans and animals. Among other findings, there are abundant data relating low serotonergic activity ± as measured by low cerebrospinal fluid 5-hydroxyindolacetic acid, and a blunted response of prolactin to fenfluramine ± to impulsive behavior. Many studies on testosterone activity show a relation between high plasma levels and a tendency towards aggression. It is hypothesized that the interaction between low serotonin and high testosterone levels in the central nervous system has a significant effect on the neural mechanisms involved in the expression of aggressive behavior. It seems that testosterone modulates serotonergic receptor activity in a way that directly affects aggression, fear and anxiety. Our survey reviews the main findings on serotonin, testosterone and the possible interaction between them with regard to these behavioral phenomena. IMAJ 2003;5:653±658 For Editorial see page 667 Aggression is a complex social behavior with many definitions. The most suitable for clinical implications is that proposed by Moyer [1]: ``An overt behavior with the intention of inflicting damage or other unpleasantness upon another individual.'' Aggression may occur in a broad spectrum of human behaviors ranging from an episodic, normal reaction to more generalized, pervasive manifes- tations in severe psychopathologies. In both humans and animals, the term aggression comprises behaviors that are non-homogenous for clinical phenomenology and neurobiologic features, making simple extrapolation from animal subtypes to humans not feasible. Nonetheless, clinical observations, experimental laboratory para- digms and cluster/factor-analytic statistics have been used in attempts to subdivide aggression in both humans and animals, thus broadening our understanding of the similar and non-similar factors that underlie aggression [2]. Violence has been defined as the physical force exerted for the purpose of violating, damaging, or abusing [3]. In humans, aggressive antisocial behavior, which is a complex phenomenon, is defined as a conduct indicating indifference to another's person or property such as criminal behavior, dishonesty or abuse [4]. Individual differences in the temperamental traits of impulsivity are relatively stable throughout life. Impulsivity is defined as actions that cannot be stopped or altered once they are initiated, even if the consequences of the action might be undesirable or unpleasant [5]. These traits are likely to result from interactions of biological and environmental factors. Brain structur- al abnormalities that are caused by genetic, nutritional-environ- mental factors may produce neuropsychologic dysfunctions. Neurotransmitters, hormones, cytokines, enzymes, growth factors, and signaling molecules are all involved in this complex neuro- circuitry that leads towards pathologic aggression. A neural circuit composed of several regions of the prefrontal cortex, amygdala, hippocampus, medial preoptic area, hypothalamus, anterior cingu- late gyrus, insular cortex, ventral striatum and other interconnected structures has been implicated in emotion regulation. Functional or structural abnormalities in one or more of these regions or in the interconnections among them can increase the susceptibility for impulsive aggression and violence [6]. Abnormalities of 5-hydroxy-tryptophan and noradrenergic func- tioning have been implicated in aggressive behavior. The role of dopamine in human studies requires further investigation. Most studies suggest that impulsive aggression is related to lower 5-HT levels in the central nervous system. While some studies show that increased levels of norepinephrine correlate with impulsive aggres- sion, others demonstrate an opposite relationship. The role of norepinephrine in impulsive aggressive behavior is still unclear [7]. Among the various factors implicated in aggression in humans and animals, a distinct link between testosterone and serotonin has been hypothesized as a major contributor [8]. In the present study we review recent findings on the effect of serotonin and testosterone on aggressive behavior and the possible link between them [Figure 1]. Testosterone Testosterone and other neurosteroids lead to sexual differentiation in the CNS. In laboratory animals it is clear that the CNS is 5-HT = 5-hydroxy-tryptophan IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 653 inherently female unless exposed to testicular hormones. Manip- ulation of the hormonal environment during perinatal development permanently alters both the structure and function of the CNS. Exposing females to testicular hormones masculinizes components of the CNS. Prenatal chemical castration or surgical castration of the male allows the development of a more female-like CNS. In mammals, the sexual differentiation of the CNS has a significant role in shaping sexual preference and other reproductive activities. In addition, it influences food intake and body weight, territorial marking and aggressive behavior, learning strategies, and play behavior. Most likely, in humans, other aspects of cognitive function are affected as well [9]. Testosterone appears to mediate its effects during a critical time period before and after birth, when it sensitizes certain neuronal circuits in the brain and guides the organization of the brain into a ``male-like'' pattern by inducing or preventing neural cell death. It has been suggested that as a result, in adulthood, when steroids stimulate these circuits again, aggressive behavior is elicited through modulation of specific neurotransmitter pathways. However, it must be remembered that hormones themselves do not directly cause behaviors; rather they induce chemical changes in certain neurons, affecting the likelihood of certain behavioral outcomes as a result of modulation of particular neural pathways [10]. Testosterone acts as a prohormone which, when converted into 5-alpha-dihydrotestosterone, acts on androgen receptors, or when converted to estradiol by the enzyme aromatase, acts on estrogen receptors. There is overwhelming evidence that most of the effects of testosterone in mediating aggression occur after aromatization [11]. Furthermore, the intensity of aggressive behavior was directly correlated with the aromatase activity in the posterior hypothala- mus [12]. Men, in general, are much more aggressive than women ± a fact that has led researchers to investigate possible links between levels of male hormones (particularly testosterone) and aggressive or criminal behavior. Testosterone may affect levels of aggression beginning early in life. In a study conducted among 28 male and 20 female preschoolers, children were videotaped while playing. Levels of aggression in social and play situations were observed and measurements of salivary testosterone levels evaluated. Results indicated a positive correlation in boys (but not in girls) between testosterone levels and serious aggression in social situations, but no correlation with playful aggression [13]. A study of 4,462 men revealed that the overall picture among the high testosterone men is one of delinquency, substance abuse and a tendency toward excess aggressive behavior. These men have more trouble with people like teachers while they are growing up, have more sexual partners, are more likely to show disciplinary problems during their military service and to have used ``hard'' drugs, particularly if they had a poor education and low incomes [14]. Measurements of testosterone saliva levels in 692 adult male prisoners showed that inmates who committed violent or sexual crimes had higher testosterone levels than inmates who were incarcerated for property crimes or drug abuse. This study also shows that inmates with higher testosterone levels violated more prison rules, especially those involving overt confrontation [15]. When salivary testosterone levels of young adult delinquents were compared with levels in a group of college students, matched for age, gender and race, the delinquent subjects had higher testosterone levels than the student controls, a finding that was true for both male and female subjects [16]. It can thus be concluded that high testosterone levels play a role in some criminal behavior, particularly when other risk factors such as low socioeconomic status are present. High testosterone levels have also been found in cases of antisocial behavior in a subtype of alcoholics. Levels of free testosterone, total testosterone, and sex hormone-binding globulin (which influences total testosterone concentration) were measured in 61 men undergoing forensic psychiatric examination. All subjects had been detoxified from drugs and alcohol while hospitalized or in prison. High concentra- tions of total testosterone and SHBG were related to type II alcoholism (a strongly genetically influenced type of alcoholism seen primarily in males, and associated with earlier onset, a more severe course, and criminality). In addition, total testosterone and SHBG were related to antisocial personality disorder and to socially deviant behavior, as reflected by scores on the Psychopathy Checklist, and free testosterone was strongly associated with the psychopathy-related scales of the Karolinska Scales of Personality [17]. In general, women have low testosterone levels. In order to learn more about the effects of this "male" hormone in females, saliva testosterone levels in 87 female inmates in a maximum security prison were compared with the violence levels of the crimes the subjects had committed, as well as the levels of aggressive dominant behavior they exhibited in prison. A direct link between testosterone and aggressively dominant behavior in prison was found. Further analysis indicated that increasing age is linked to reduced criminal violence and aggressive dominance in female prisoners, both directly and indirectly through lower levels of testosterone that come with age. Five women with the lowest testosterone levels were described by prison staff members to be "sneaky" and "treacherous." Observing the well-established link Reviews SHBG = sex hormone-binding globulin 654 M. Birger et al. IMAJ . Vol 5 . September 2003 between testosterone and dominance, it is hypothesized that when dominant high testosterone inmates face confrontation, they act openly and directly, while low testosterone inmates, because they are less dominant, need to be more ``sneaky'' in dealing with others [18]. The conclusion derived from accumulating evidence in humans and animals indicates that high testosterone levels are related to dominance-related aggression implicated in normal and pathologic behaviors. Serotonin The brainstem raphe 5-HT system is the most widely distributed neurotransmitter system in the brain. Serotonergic raphe neurons project diffusely to a variety of brain regions (e.g., cortex, amygdala, and hippocampus). In addition to its role as a neurotransmitter, 5- HT is an important regulator of morphogenetic activities during early brain development as well as during adult neurogenesis and plasticity, including cell proliferation, migration, differentiation and synaptogenesis [19]. In humans, non-human primates and other mammals, preclini- cal and clinical studies have accumulated an overwhelming body of evidence indicating that 5-HT signaling is a major modulator of emotional behavior, including anxiety and impulsivity as well as aggression, and integrates complex brain functions such as cognition, sensory processing and motor activity [20]. The diversity of these functions is due to the fact that 5-HT orchestrates the activity and interaction of several other transmitter systems. 5-HT may be viewed as a master-control neurotransmitter within a highly complex system of neural communication mediated by at least 14 pre- and postsynaptic receptor subtypes and subunits. 5-HT synthesizing and metabolizing enzymes, and the 5-HT transporter, play an important role in the regulation of 5-HT, which acts as a chemical messenger. 5-HT-mediated behaviors may be diversely expressed and range from minor personality accentuations (char- acterized by impulsivity, hostility, irritability, psychopathic deviance or violence, or by more clear-cut personality dysfunction such as antisocial, borderline, narcissistic and histrionic personality traits or disorders) to major psychiatric disturbances (suicidal behavior, overt aggressive behavior, intermittent explosive disorder, patholo- gic gambling, pyromania, bulimia, and some types of substance or alcohol abuse) [21]. One of the most replicated findings in psychobiology is the observation of lower 5-hydroxyindolacetic acid in the brain and cerebrospinal fluid of subjects with impulsive aggression and suicidal behavior. Low or lower than average 5-HIAA concentrations in cerebrospinal fluid have been reported in individuals who display inappropriate aggression as children, engage in frequent impulsive and violent criminal behavior, exhibit excessive alcohol abuse and dependence, and in high lethality suicide attempters as opposed to low lethality suicide attempters. Lifetime levels of aggression were found to be higher among individuals with lower CSF levels of 5-HIAA suffering from depression. In contrast, the dopamine and norepinephrine systems do not appear to be as significantly involved in suicidal acts, aggression, or depression. [22]. In a study of wild and captive primates, 49 male rhesus monkeys were studied for 4 years. During this time, young monkeys were undergoing a very dangerous period of life during which they migrated from their own groups to new social groups. Between 30% and 50% of the monkeys died during this period, often from violent encounters with other monkeys. (This particular colony of monkeys has no natural enemies.) At the beginning of the study, 5-HIAA levels were measured and the monkeys were divided into four groups: low, mid-low, mid-high, and high 5-HIAA. Twenty-seven of the monkeys were observed in the wild and the monkeys' aggressive acts were recorded. The aggressive acts of all 49 monkeys while in captivity, as well as the monkeys' fight-related scars and wounds, were also recorded. Low CSF 5-HIAA concentrations were predictive of the early death of 11 subjects of the monkey group that were either known or presumed dead. Direct observations of aggressive behavior showed that subjects that died had engaged in high rates of escalated aggression and exhibited a trend to engage in more overall aggression. Of the six dead monkeys whose bodies were recovered, all four who died violently had low 5-HIAA levels, while the two monkeys that died of illnesses had 5-HIAA levels similar to those of the surviving monkeys. While monkeys with low 5-HIAA levels were more violent than the high 5-HIAA monkeys, they also had other dangerous personality traits. They migrated at earlier ages when they were less prepared to defend themselves, were more likely to take life-threatening risks such as spontaneous jumping at dangerous heights when moving from tree to tree, and were most likely to be caught repeatedly in traps. [23]. The increased death rate among monkeys with low 5-HIAA levels is consistent with the results of a 1993 study conducted in a mixed- diagnosis group of 73 male psychiatric patients examined between 1976 and 1990 and diagnosed as suffering predominantly from schizophrenia and depression. Seven of these patients later died before the age of 40. All seven had markedly lower CSF 5-HIAA levels than the surviving patients, and six of the seven died either in homicides, suicides, or "suspicious" accidents [24]. An increase in plasma prolactin when the drug fenfluramine is administered is one measure of the responsiveness of the serotonergic system. The administration of the serotonin-releasing agent D-fenfluramine to 35 healthy subjects (20 females and 15 males) caused an inverse correlation between measures of serotonin function and measures of hostility and aggression in male subjects [25]. These data provide modest support for the theory of a link between reduced serotonergic activity and increased trait aggression in healthy males. No similar correlation was seen in female subjects. A fenfluramine challenge to 97 personality- disordered patients revealed that those with a history of self-injury or suicide attempts displayed evidence of abnormalities of the serotonergic system [26]. Research on deactivation of 5-HT receptors also indicated that 5-HT is connected to impulsivity and aggression-related behavior. The 5-HT1B receptor was the first subtype to have its gene deactivated. These receptors are located predominantly at presynaptic terminals where they can inhibit release of 5-HT. Wild-type and homozygous null mutant (5-HT1B) Reviews 5-HIAA = 5-hydroxyindolacetic acid CSF = cerebrospinal fluid IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 655 showed more rapid, more intense, and more frequent attacks when being intruded than the non-isolated male wild-type [27]. In contrast to 5-HT1B knockout in mice, 5-HT1A knockouts are less reactive and possibly less aggressive but show more anxiety-related behavior than control mice [28]. In humans, significant sib-pair linkage of antisocial alcoholism was associated with 5-HT1B gene HTR1B G861C polymorphism and the short-tandem repeat locus D6S284 [29]. The first step in 5-HT biosynthesis in 5-HT neurons is catalyzed by the rate-limiting enzyme tryptophan hydroxylase. Involvement of L-tryptophan availability and of TPH activity in impulsivity, aggressiveness, and associated suicidality has been reported in several studies of psychiatric patients or offender populations [30]. An increase was recently observed in aggressive responses on a free-operant laboratory measure of aggression following experi- mental tryptophan depletion in healthy males, supporting the hypothesis that low plasma tryptophan concentration and asso- ciated decrease in brain 5-HT facilitates aggression-related behavior [31]. Although some studies show a controversial trend, i.e., that elevated serotonergic activity leads to increased aggression [32], the majority of research data in humans and animal models do show a correlation between aggressive behavior and low CNS serotonergic activity. This is demonstrated by low CSF 5-HIAA levels, fenfluramine challenge, tryptophan depletion, and mice knockout paradigms. The relation between testosterone and serotonin A study that measured CSF testosterone and 5-HIAA showed that: . CSF free testosterone concentrations were positively correlated with overall aggressiveness, but not with measures of impulsiv- ity. . CSF 5-HIAA concentrations were negatively correlated with impulsive behavior and with severe, unrestrained aggression, but not with overall rates of aggression. High rates of impulsive behavior were positively correlated with severe, unrestrained aggression, but not overall rates of aggression. . Dimensional analyses showed that while subjects with low CSF 5-HIAA exhibited high rates of aggression, high CSF testosterone further augmented rates and intensity of aggression in subjects with low CSF 5-HIAA [33]. It is thus concluded that high CSF free testosterone concentrations are associated with competitive aggression, while low CSF 5-HIAA concentrations are associated with severe aggression, which results from impaired impulse control and perseverance [34]. The relationship between impulsivity, aggression, 5-HT function and testosterone in male offenders with personality disorders was investigated in 60 male offenders with personality disorders and 27 healthy controls, using the Special Hospital Assessment of Personality and Socialization score. Non-psychopaths and those with schizoid personality disorders according to SHAPS had enhanced 5-HT function (prolactin response to d-fenfluramine). Reduced 5-HT function was found in offenders with borderline personality disorders and those with a history of repeated self-harm or alcohol misuse. The 5-HT function was inversely correlated more strongly with impulsivity than with aggression. Plasma testosterone correlated positively with aggressive acts. The SHAPS primary psychopaths had lower initial cortisol and higher testosterone concentrations than controls [8]. Acute administration of testoster- one in male rats caused a significant increase in the content of 5- HT2A receptor mRNA and serotonin transporter mRNA in the dorsal raphe nucleus and the density of 5-HT2A receptor and serotonin binding sites in higher centers of the brain. The lack of effect of 5- alpha-dihydrotestosterone, a potent androgen that cannot be converted to estrogen, suggests that the action of testosterone depends upon its conversion to estrogen by aromatase. This may also explain why estrogen, but not testosterone, increased the density of 5-HT2AR binding sites in the caudate-putamen, a brain region where aromatase is scarce. These findings provide a potential topochemical handle with which to investigate testosterone/estrogen regulation of serotonin- related gene expression. The possible role of interactions between sex steroids and serotonin mechanisms might serve as an etiologic model to psychopathology leading to aggression [35]. The administration of paroxetine, a selective serotonin reuptake inhibitor, did not have any effect on night-time testosterone profiles in healthy male volunteers [36]. In a study examining the relationship between 5-HT, testosterone and alcoholism in the etiology of domestic violence, it was shown that: . Healthy controls and domestic violence in the non-alcoholic group differed in 5-HIAA concentrations and physical violence scores. . Healthy controls and domestic violence alcoholic groups differed in testosterone concentrations, alcohol dependence and physical violence scores. . The domestic violence non-alcoholic and domestic violence alcoholic groups differed in 5-HIAA, testosterone concentra- tions, physical violence scores and alcohol dependence [37]. Although studies link high levels of testosterone to aggression, this hormone alone does not account for aggressive behavior. In fact, successful athletes and businessmen tend to have high testosterone levels, without being any more violence-prone than their low testosterone counterparts, indicating that testosterone may not act alone in promoting aggression. Rather, aggressive men's behavior may be influenced by high testosterone levels combined with low levels of the brain chemical serotonin. Testosterone is linked more strongly to dominance in general than to aggression. High testosterone levels encourage dominance- seeking behaviors, which put the individual into situations in which frustration of dominance can occur. It is postulated that when a high testosterone man is frustrated in his attempts to achieve dominance, serotonin comes into play, because low serotonin activity is associated with hyper-responsiveness to aversive stimuli and therefore results in a greater likelihood of an intensely negative emotional reaction and, thus, a greater chance of aggressive behavior. It is speculated that the hypothalamus and amygdala, which are prominently associated with both testosterone and Reviews TPH = tryptophan hydroxylase SHAPS = Special Hospital Assessment of Personality and Socialization 656 M. Birger et al. IMAJ . Vol 5 . September 2003 serotonin, play a key role in aggressive responses to situations in which efforts at dominance are frustrated. In comparison to non- aggressive animals, aggressive animals were found to have lower serotonin levels in the hypothalamus and the amygdala. Testoster- one action in both of these brain structures was shown to increase aggression in various animal species [38]. Conclusions Biological influences are not the only pathway leading to individual differences in personality dimensions, behavior, and psychopathol- ogy. Complex traits are most likely generated by a complex interaction of environmental and experiential factors with a number of biological factors, among which testosterone and serotonin play a major role. Recent genetic studies on 5-HT receptors, transpor- ters, and modifying enzymes have shown that although these substances have only a modest impact, they affect many develop- mental processes throughout ontogeny as well as compensatory mechanisms. The therapeutic application of these findings includes the use of agents that increase 5-HT, either by facilitating its release such as fenfluramine or by blocking its reuptake by the various selective serotonin reuptake inhibitors [39]. Chemical castration by antian- drogenic agents, although inefficient for treating general aggres- sion, is used for the treatment of paraphilic sex offenders [40]. It is becoming increasingly evident that many neurotransmitters and hormones are expressed at early periods of neural development and it is likely that they participate in the structural organization of the nervous system. A major challenge is therefore the identifica- tion of specific neural mechanisms that underlie aggressiveness and impulsivity for the purpose of early identification, prevention and the treatment of individuals who are prone to violent acts. References 1. Moyer K. Kinds of aggression and their physiological basis. In: Buglass R, Bowden P, eds. Principles and Practice of Forensic Psychiatry. Community and Behavioural Biology. Part A. Edinburgh: Churchill Livingstone, 1968. 2. Scarpa A, Raine A. Psychophysiology of anger and violent behavior. Psychiatr Clin North Am 1997;20:375±94. 3. The American Heritage Dictionary of the English Language. 4th edn. New York: Houghton Mifflin, 2000. 4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association, 1994. 5. Logan GD, Schachar RJ, Tannock R. Impulsivity and inhibitory control. Psych Sci 1997;8:60±4. 6. Davidson RJ. Dysfunction in the neural circuitry of emotion regulation ± a possible prelude to violence. Science 2000;289:591±4. 7. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000;23:11±25. 8. Dolan M, Anderson IM, Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 2001;178:352±9. 9. Gorski RA. Development of the cerebral cortex. XV: Sexual differentiation of the central nervous system. J Am Acad Child Adolesc Psychiatry 1998;37:1337±9. 10. Ewen B. Endocrine effects on the brain and their relationship to behavior. In: Siegel G, ed. Basic Neurochemistry. 5th edn. London: Raven Press, 1994:1007±26. 11. Schlinger BA, Callard GV. Aromatization mediates aggressive behavior in quail. Gen Compar Endocrinol 1990;79:39±53. 12. Schlinger BA, Callard GV. Aromatase activity in quail brain: correlation with aggressiveness. Endocrinology 1989;124:437±43. 13. Sanchez-Martin E, Fano L, Ahedo J, et al. Relating testosterone levels and free play social behavior in male and female preschool children. Psychoneuroendocrinology 2000;8:773±83. 14. Dabbs JM, Morris R. Testosterone, social class, and antisocial behavior in a sample of 4,462 men. Psychol Sci 1990;1:209±11. 15. Dabbs JM, Carr TS, Frady, Rl, et al. Testosterone, crime, and misbehavior among 692 male prison inmates. Person Individ Diff 1995;18:627±33. 16. Banks T, Dabbs JM. Salivary testosterone and cortisol in a delinquent and violent urban subculture. J Soc Psychol 1996;136:49±56. 17. Stalenheim EG, Eriksson E, von Knorring L, et al. Testosterone as a biological marker in psychopathy and alcoholism. Psychiatr Res 1998;77:79±88. 18. Dabbs JM, Hargrove MF. Age, testosterone, and behavior among female prison inmates. Psychosom Med 1997;59:477±80. 19. Azmitia EC, Whitaker-Azmitia PM. Development and adult plasticity of serotonergic neurons and their target cells. In: Baumgarten HG, Gothert M, eds. Serotonergic Neurons and 5-HT Receptors in the CNS. New York: Springer, 1997:1±39. 20. Westenberg HG, Murphy DL, Den Boer JA. Advances in the Neurobiology of Anxiety Disorders. New York: Wiley, 1996. 21. Staner L, Mendlewicz J. Heredity and role of serotonin in aggressive impulsive behavior. Encephale 1998;24:355±64. 22. Asberg M. Neurotransmitters and suicidal behavior: the evidence from cerebrospinal fluid studies. Ann NY Acad Sci 1997;836:158±81. 23. Higley JD, Mehlman PT, Higley SB, et al. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 1996;53: 537±43. 24. Faustman WO, Ringo DL, Faull KF. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Br J Psychiatry 1993;163:519±21. 25. Cleare AJ, Bond, AJ. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatr Res 1997;69:89±95. 26. New AS, Trestman RL, Mitropolou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatr Res 1997;69:17±26. 27. Ramboz S, Saudou F, Amara DA, et al. 5-HT1B receptor knock out- behavioral consequences. Behav Brain Res 1996;73:305±12. 28. Zhuang X, Gross C, Santarelli L, et al. Altered motional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharma- cology 1999;21:52±60S. 29. Lappalainen J, Long JC, Eggert M, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998;55:989±94. 30. LeMarquand DG, Benkalfat C, Pihl RO, et al. Behavioral inhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry 1999;156:1771±9. 31. Wingrove J, Bond AJ, Cleare AJ, et al. Trait hostility and prolactin response to tryptophan enhancement/depletion. Neuropsychobiology 1999;40:202±6. 32. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527±31. 33. Higley JD, Mehlman PT. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 1996;40:1067±82. 34. Higley JD, Mehlman PT. Comment on the article: CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors Biol Psychiatry 1997;42:305±7. 35. Fink G, Sumner B, Rosie R, et al. Androgen actions on central serotonin Reviews IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 657 neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 1999;105:53±68. 36. Schlosser R, Wetzel H, Dorr H, et al. Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers. Psychoneuroendocrinology 2000;25:377±88. 37. George DT, Umau JC, Philips MJ, et al. Serotonin, testosterone and alcohol in the etiology of domestic violence. Psychiatr Res 2001;104:27± 37 38. Bernhardt PC. Influences of serotonin and testosterone in aggression and dominance: convergence with social psychology. Curr Direc Psychol Sci 1997;6:44±8. 39. Coccaro EF, Kavoussi RJ. Fluxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 1997;54:1081±8. 40. Rosler A, Witztum E. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 2000;18:43±56. Correspondence: Dr. M. Birger, Forensic Psychiatric Services, Magen Prison, P.O. Box 2058, Ramleh 72100, Israel. Phone: (972-8) 977-6142 Fax: (972-8) 977-6141 email: bymoshe@beer-ness.health.gov.il Reviews

Labels: , ,

----- -------- /* ----------------------------------------------- Blogger Template Style Name: Son of Moto (Mean Green Blogging Machine variation) Designer: Jeffrey Zeldman URL: www.zeldman.com Date: 23 Feb 2004 ----------------------------------------------- */ /* Primary layout */ body { margin: 0; padding: 0; border: 0; text-align: center; color: #554; background: #692 url(http://www.blogblog.com/moto_son/outerwrap.gif) top center repeat-y; font: small tahoma, "Bitstream Vera Sans", "Trebuchet MS", "Lucida Grande", lucida, helvetica, sans-serif; } img { border: 0; display: block; } /* Wrapper */ @media all { #wrapper { margin: 0 auto; padding: 0; border: 0; width: 692px; text-align: left; background: #fff url(http://www.blogblog.com/moto_son/innerwrap.gif) top right repeat-y; font-size:90%; } } @media handheld { #wrapper { width: 90%; } } /* Header */ #blog-header { color: #ffe; background: #8b2 url(http://www.blogblog.com/moto_son/headbotborder.gif) bottom left repeat-x; margin: 0 auto; padding: 0 0 15px 0; border: 0; } #blog-header h1 { font-size: 24px; text-align: left; padding: 15px 20px 0 20px; margin: 0; background-image: url(http://www.blogblog.com/moto_son/topper.gif); background-repeat: repeat-x; background-position: top left; } #blog-header p { font-size: 110%; text-align: left; padding: 3px 20px 10px 20px; margin: 0; line-height:140%; } /* Inner layout */ #content { padding: 0 20px; } @media all { #main { width: 400px; float: left; } #sidebar { width: 226px; float: right; } } @media handheld { #main { width: 100%; float: none; } #sidebar { width: 100%; float: none; } } /* Bottom layout */ #footer { clear: left; margin: 0; padding: 0 20px; border: 0; text-align: left; border-top: 1px solid #f9f9f9; background-color: #fdfdfd; } #footer p { text-align: left; margin: 0; padding: 10px 0; font-size: x-small; background-color: transparent; color: #999; } /* Default links */ a:link, a:visited { font-weight : bold; text-decoration : none; color: #692; background: transparent; } a:hover { font-weight : bold; text-decoration : underline; color: #8b2; background: transparent; } a:active { font-weight : bold; text-decoration : none; color: #692; background: transparent; } /* Typography */ #main p, #sidebar p { line-height: 140%; margin-top: 5px; margin-bottom: 1em; } .post-body { line-height: 140%; } h2, h3, h4, h5 { margin: 25px 0 0 0; padding: 0; } h2 { font-size: large; } h3.post-title { margin-top: 5px; font-size: medium; } ul { margin: 0 0 25px 0; } li { line-height: 160%; } #sidebar ul { padding-left: 10px; padding-top: 3px; } #sidebar ul li { list-style: disc url(http://www.blogblog.com/moto_son/diamond.gif) inside; vertical-align: top; padding: 0; margin: 0; } dl.profile-datablock { margin: 3px 0 5px 0; } dl.profile-datablock dd { line-height: 140%; } .profile-img {display:inline;} .profile-img img { float:left; margin:0 10px 5px 0; border:4px solid #8b2; } #comments { border: 0; border-top: 1px dashed #eed; margin: 10px 0 0 0; padding: 0; } #comments h3 { margin-top: 10px; margin-bottom: -10px; font-weight: normal; font-style: italic; text-transform: uppercase; letter-spacing: 1px; } #comments dl dt { font-weight: bold; font-style: italic; margin-top: 35px; padding: 1px 0 0 18px; background: transparent url(http://www.blogblog.com/moto_son/commentbug.gif) top left no-repeat; color: #998; } #comments dl dd { padding: 0; margin: 0; } .deleted-comment { font-style:italic; color:gray; } /* Feeds ----------------------------------------------- */ #blogfeeds { } #postfeeds { }

Adopt Biomed

This blog gathers information about biomedical interventions for children with adoption trauma and Reactive Attachment Disorder. Posts are gathered from multiple websites in one place. Most posts contain unedited text relating to biomedical treatment, dietary changes, vitamins, homeopathy, herbs, etc. Where possible, the link to the original information is included.

Thursday, January 15, 2009

Serotonin's effects on multiple body systems

One Dangerous Deficiency Links IBS, Migraines, and More Health News By VRP Staff When you think of serotonin deficiency, the first consequence that might spring to mind is depression. And if so, you’d be right. But there’s more to this neurotransmitter than meets the eye—a lot more. Migraines, irritable bowel syndrome, fibromyalgia, obesity, even asthma… believe it or not, all of these serious conditions can be traced back to depleted serotonin levels. And the effects on your body can be as damaging as they are diverse. Serotonin is one of your brain’s most crucial messengers. It’s released by your neurons to send signals to other neurons, after which it’s returned to its original parent neuron to be reused. But if your levels are low, serotonin’s time on your synapse is cut short. It’s recaptured before it can finish its job—at a very high cost to your health, mentally and physically. In addition to depression, low levels of serotonin–and its precursor tryptophan–have been linked to binge eating, carbohydrate cravings, and weight gain.1 Studies show that obese and overweight diabetic patients have levels that are well below normal–and in clinical trials, increased brain serotonin led to both reduced caloric intake and resulting weight loss.2–4 But it’s not just your waistline that benefits from this critical neurotransmitter. Studies have shown that increasing serotonin levels can fight insomnia by improving sleep continuity.5 Research also shows that increased serotonin relieves migraines as effectively as standard drug therapy and aids in relief of chronic tension headaches.6–7 This same ability has made it a unique target in the treatment of fibromyalgia, with serotonin deficiency implicated for lower pain thresholds and higher clinical measures of perceived pain in patients.8–10 In an even more surprising connection, serotonin has also been identified as a major player in gut motility.11–12 Special serotonin–releasing cells can be found throughout your digestive system, responsible for stimulating peristaltic motion and pushing waste through your digestive tract.13 Even the development and severity of asthma has been linked to depression, anxiety, and low–serotonin related disorders—revealing yet another function under this neurotransmitter’s powerful influence.14 Proper levels of serotonin are essential for your health—and one way to ensure higher levels of this neurotransmitter is by boosting your intake of tryptophan, an essential amino acid found in high–protein foods that is responsible for serotonin synthesis in your brain. Research has shown that supplementing with tryptophan (and its metabolite 5–hydroxytryptophan, or 5–HTP) can replenish serotonin naturally and effectively—easing depression, anxiety, migraines, insomnia, and fibromyalgia symptoms in several clinical studies.15–17 References: 1. Gendall KA, Joyce PR. Meal–induced changes in tryptophan:LNAA ratio: effects on craving and binge eating. Eat Behav. 2000 Sep;1(1):53–62. 2. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty–four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003 May;77(5):1112–1118. 3. Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5–hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76(2):109–117. 4. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5–hydroxytryptophan. Am J Clin Nutr 1992 Nov;56(5):863–867. 5. Riemann D, Vorderholzer U. Treatment of depression and sleep disorders. Significance of serotonin and L–tryptophan in pathophysiology and therapy. Fortschr Med. 1998 Nov;116(32):40–42. 6. Titus F, Dávalos A, Alom J, Codina A. 5–Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol. 1986;25(5):327–329. 7. Ribeiro CA. L–5–Hydroxytryptophan in the prophylaxis of chronic tension–type headache: a double–blind, randomized, placebo–controlled study. For the Portuguese Head Society. Headache. 2000 Jun;40(6):451–456. 8. Birdsall TC. 5–Hydroxytryptophan: a clinically–effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271–280. 9. Hrycaj P, Stratz T, Muller W. Platelet 3Himipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1993;20:1986–1988. [letter] 10. Russell IJ, Michalek JE, Vipraio GA, et al. Platelet 3H–imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104–109. 11. Fayyaz M, Lackner JM. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag. 2008 Feb;4(1):41–48. 12. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Minneap). 1999 Jul 15;34(7):31–32,35–38,41–42. 13. Grider JR. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5–HT4 agonist tegaserod. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G319–G327. 14. Goodwin RD, Sourander A, Duarte CS, et al. Do mental health problems in childhood predict chronic physical conditions among males in early adulthood? Evidence from a community–based prospective study. Psychol Med. 2008 May 28:1–11. 15. Poldinger W, Calanchini B, Schwarz W. A functional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5–hydroxytryptophan and fluvoxamine. Psychopathology. 1991;24:53–81. 16. Kahn RS, Westenberg HG. L–5–hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord. 1985 Mar–Apr;8(2):197–200. 17. Puttini PS, Caruso I. Primary fibromyalgia and 5–hydroxy–L–tryptophan: a 90 day open study. J Int Med Res. 1992;20:182–189.

Labels: , , , , , ,

Tuesday, April 29, 2008

PTSD and neurobiology

The Body Keeps The Score:
Memory & the Evolving Psychobiology of Post Traumatic Stress
by Bessel van der Kolk


Bessel A. van der Kolk, MD.
Harvard Medical School
HRI Trauma Center
227 Babcock Street
Boston, MA 02146

This is a version of an article first published in the Harvard Review of Psychiatry, 1994, 1(5), 253-265. Note that this online version may have minor differences from the published version.
The author wishes to thank Rita Fisler, Ed.M. for her editorial assistance.
Background

For more than a century, ever since people's responses to overwhelming experiences were first systematically explored, it has been noted that the psychological effects of trauma are expressed as changes in the biological stress response. In 1889, Pierre Janet (1), postulated that intense emotional reactions make events traumatic by interfering with the integration of the experience into existing memory schemes. Intense emotions, Janet thought, cause memories of particular events to be dissociated from consciousness, and to be stored, instead, as visceral sensations (anxiety and panic), or as visual images (nightmares and flashbacks). Janet also observed that traumatized patients seemed to react to reminders of the trauma with emergency responses that had been relevant to the original threat, but that had no bearing on current experience. He noted that victims had trouble learning from experience: unable to put the trauma behind them, their energies were absorbed by keeping their emotions under control at the expense of paying attention to current exigencies. They became fixated upon the past, in some cases by being obsessed with the trauma, but more often by behaving and feeling like they were traumatized over and over again without being able to locate the origins of these feelings (2,3).

Freud also considered the tendency to stay fixated on the trauma to be biologically based: "After severe shock.. the dream life continually takes the patient back to the situation of his disaster from which he awakens with renewed terror.. the patient has undergone a physical fixation to the trauma"(4). Pavlov's investigations continued the tradition of explaining the effects of trauma as the result of lasting physiological alterations. He, and others employing his paradigm, coined the term "defensive reaction" for a cluster of innate reflexive responses to environmental threat (5). Many studies have shown how the response to potent environmental stimuli (unconditional stimuli-US) becomes a conditioned reaction. After repeated aversive stimulation, intrinsically non-threatening cues associated with the trauma (conditional stimuli-CS) become capable of eliciting the defensive reaction by themselves (conditional response-CR). A rape victim may respond to conditioned stimuli, such as the approach by an unknown man, as if she were about to be raped again, and experience panic. Pavlov also pointed out that individual differences in temperament accounted for the diversity of long term adaptations to trauma.

Abraham Kardiner(6), who first systematically defined posttraumatic stress for American audiences, noted that sufferers from "traumatic neuroses" develop an enduring vigilance for and sensitivity to environmental threat, and stated that "the nucleus of the neurosis is a physioneurosis. This is present on the battlefield and during the entire process of organization; it outlives every intermediary accommodative device, and persists in the chronic forms. The traumatic syndrome is ever present and unchanged". In "Men under Stress", Grinker and Spiegel (7) catalogue the physical symptoms of soldiers in acute posttraumatic states: flexor changes in posture, hyperkinesis, "violently propulsive gait", tremor at rest, masklike facies, cogwheel rigidity, gastric distress, urinary incontinence, mutism, and a violent startle reflex. They noted the similarity between many of these symptoms and those of diseases of the extrapyramidal motor system. Today we can understand them as the result of stimulation of biological systems, particularly of ascending amine projections. Contemporary research on the biology of PTSD, generally uninformed by this earlier research, confirms that there are persistent and profound alterations in stress hormones secretion and memory processing in people with PTSD.
The Symptomatology of PTSD

Starting with Kardiner(6), and closely followed by Lindemann (8), a vast literature on combat trauma, crimes, rape, kidnapping, natural disasters, accidents and imprisonment have shown that the trauma response is bimodal: hypermnesia, hyper-reactivity to stimuli and traumatic reexperiencing coexist with psychic numbing, avoidance, amnesia and anhedonia (9,10,11,12). These responses to extreme experiences are so consistent across traumatic stimuli that this biphasic reaction appears to be the normative response to any overwhelming and uncontrollable experience. In many people who have undergone severe stress, the post-traumatic response fades over time, while it persists in others. Much work remains to be done to spell out issues of resilience and vulnerability, but magnitude of exposure, prior trauma, and social support appear to be the three most significant predictors for developing chronic PTSD (13,14).

In an apparent attempt to compensate for chronic hyperarousal, traumatized people seem to shut down: on a behavioral level, by avoiding stimuli reminiscent of the trauma; on a psychobiological level, by emotional numbing, which extends to both trauma-related, and everyday experience (15). Thus, people with chronic PTSD tend to suffer from numbing of responsiveness to the environment, punctuated by intermittent hyperarousal in response to conditional traumatic stimuli. However, as Pitman has pointed out (16), in PTSD, the stimuli that precipitate emergency responses may not be conditional enough: many triggers not directly related to the traumatic experience may precipitate extreme reactions. Thus, people with PTSD suffer both from generalized hyperarousal and from physiological emergency reactions to specific reminders(9,10) The loss of affective modulation that is so central in PTSD mayhelp explain the observation that traumatized people lose the capacity to utilize affect states as signals (18). Instead of using feelings as cues to attend to incoming information, in people with PTSD arousal is likely to precipitate flight or fight reactions (19). Thus, they are prone to go immediately from stimulus to response without making the necessary psychological assessment of the meaning of what is going on. This makes them prone to freeze, or, alternatively, to overreact and intimidate others in response to minor provocations (12,20).
Psychophysiology

Abnormal psychophysiological responses in PTSD have been demonstrated on two different levels: 1) in response to specific reminders of the trauma and 2) in response to intense, but neutral stimuli, such as acoustic startle. The first paradigm implies heightened physiological arousal to sounds, images, and thoughts related to specific traumatic incidents. A large number of studies have confirmed that traumatized individuals respond to such stimuli with significant conditioned autonomic reactions, such as heart rate, skin conductance and blood pressure (20,21,22,23, 24,25). The highly elevated physiological responses that accompany the recall of traumatic experiences that happened years, and sometimes decades before, illustrate the intensity and timelessness with which traumatic memories continue to affect current experience (3,16). This phenomenon has generally been understood in the light of Peter Lang's work (26) which shows that emotionally laden imagery correlates with measurable autonomic responses. Lang has proposed that emotional memories are stored as "associative networks", that are activated when a person is confronted with situations that stimulate a sufficient number of elements that make up these networks. One significant measure of treatment outcome that has become widely accepted in recent years is a decrease in physiological arousal in response to imagery related to the trauma (27). However, Shalev et al (28) have shown that desensitization to specific trauma-related mental images does not necessarily generalize to recollections of other traumatic events, as well.

Kolb (29) was the first to propose that excessive stimulation of the CNS at the time of the trauma may result in permanent neuronal changes that have a negative effect on learning, habituation, and stimulus discrimination. These neuronal changes would not depend on actual exposure to reminders of the trauma for expression. The abnormal startle response characteristic of PTSD (10) exemplifies such neuronal changes.

Despite the fact that an abnormal acoustic startle response (ASR) has been seen as a cardinal feature of the trauma response for over half a century, systematic explorations of the ASR in PTSD have just begun. The ASR consists of a characteristic sequence of muscular and autonomic responses elicited by sudden and intense stimuli (30,31). The neuronal pathways involved consist of only a small number of mediating synapses between the receptor and effector and a large projection to brain areas responsible for CNS activation and stimulus evaluation (31). The ASR is mediated by excitatory amino acids such as glutamate and aspartate and is modulated by a variety of neurotransmitters and second messengers at both the spinal and supraspinal level (32). Habituation of the ASR in normals occurs after 3 to 5 presentations (30).

Several studies have demonstrated abnormalities in habituation to the ASR in PTSD (33,34,35,36). Shalev et al (33) found a failure to habituate both to CNS and ANS-mediated responses to ASR in 93% of the PTSD group, compared with 22% of the control subjects. Interestingly, people who previously met criteria for PTSD, but no longer do so now, continue to show failure of habituation of the ASR (van der Kolk et al, unpublished data; Pitman et al, unpublished data), which raises the question whether abnormal habituation to acoustic startle is a marker of, or a vulnerability factor for developing PTSD.

The failure to habituate to acoustic startle suggests that traumatized people have difficulty evaluating sensory stimuli, and mobilizing appropriate levels of physiological arousal(30). Thus, the inability of people with PTSD to properly integrate memories of the trauma and, instead, to get mired in a continuous reliving of the past, is mirrored physiologically in the misinterpretation of innocuous stimuli, such as the ASR, as potential threats.
The Hormonal Stress Response & the Psychobiology of PTSD

Post Traumatic Stress Disorder develops following exposure to events that are intensely distressing. Intense stress is accompanied by the release of endogenous, stress-responsive neurohormones, such as cortisol, epinephrine and norepinephrine (NE), vasopressin, oxytocin and endogenous opioids. These stress hormones help the organism mobilize the required energy to deal with the stress, ranging from increased glucose release to enhanced immune function. In a well-functioning organism, stress produces rapid and pronounced hormonal responses. However, chronic and persistent stress inhibits the effectiveness of the stress response and induces desensitization (37).

Much still remains to be learned about the specific roles of the different neurohormones in the stress response. NE is secreted by the Locus Coeruleus(LC) and distributed through much of the CNS, particularly the neocortex and the limbic system, where it plays a role in memory consolidation and helps initiate fight/ flight behaviors. Adrenocorticotropin (ACTH) is released from the anterior pituitary, and activates a cascade of reactions, eventuating in release of glucocorticoids from the adrenals. The precise interrelation between Hypothalamic-Pituitary-Adrenal (HPA) Axis hormones and the catecholamines in the stress response is not entirely clear, but it is known that stressors that activate NE neurons also increase CRF concentrations in the LC (38), while intracerebral ventricular infusion of CRF increases NE in the forebrain (39). Glucocorticoids and catecholamines may modulate each other's effects: in acute stress, cortisol helps regulate stress hormone release via a negative feedback loop to the hippocampus, hypothalamus and pituitary (40) and there is evidence that corticosteroids normalize catecholamine-induced arousal in limbic midbrain structures in response to stress (41). Thus, the simultaneous activation of corticosteroids and catecholamines could stimulate active coping behaviors, while increased arousal in the presence of low glucocorticoid levels may promote undifferentiated fight or flight reactions (42).

While acute stress activates the HPA axis and increases glucocorticoid levels, organisms adapt to chronic stress by activating a negative feedback loop that results in 1) decreased resting glucocorticoid levels in chronically stressed organisms, (43), 2) decreased glucocorticoid secretion in response to subsequent stress (42), and 3) increased concentration of glucocorticoid receptors in the hippocampus (44). Yehuda has suggested that increased concentration of glucocorticoid receptors could facilitate a stronger glucocorticoid negative feedback, resulting in a more sensitive HPA axis and a faster recovery from acute stress (45).

Chronic exposure to stress affects both acute and chronic adaptation: it permanently alters how an organism deals with its environment on a day-to-day basis, and it interferes with how it copes with subsequent acute stress (45).
Neuroendocrine Abnormalities in PTSD

Since there is an extensive animal literature on the effects of inescapable stress on the biological stress response of other species, such as monkeys and rats, much of the biological research on people with PTSD has focussed on testing the applicability of those research findings to people with PTSD (46,47). People with PTSD, like chronically and inescapbly shocked animals, seem to suffer from a persistent activation of the biological stress response upon exposure to stimuli reminiscent of the trauma.

1) Catecholamines. Neuroendocrine studies of Vietnam veterans with PTSD have found good evidence for chronically increased sympathetic nervous system activity in PTSD. One study (48) found elevated 24h excretions of urinary NE and epinephrine in PTSD combat veterans compared with patients with other psychiatric diagnoses. While Pitman & Orr (49) did not replicate these findings in 20 veterans and 15 combat controls, the mean urinary NE excretion values in their combat controls (58.0 ug/day) were substantially higher than those previously reported in normal populations. The expected compensatory downregulation of adrenergic receptors in response to increased levels of norepinephrine was confirmed by a study that found decreased platelet alpha-2 adrenergic receptors in combat veterans with PTSD, compared with normal controls (50). Another study also found an abnormally low alpha-2 adrenergic receptor-mediated adenylate cyclase signal transduction (51). In a recent study Southwick et al (52) used yohimbine injections (0.4 mg/kg), which activate noradrenergic neurons by blocking the alpha-2 auto- receptor, to study noradrenergic neuronal dysregulation in Vietnam veterans with PTSD. Yohimbine precipitated panic attacks in 70% of subjects and flashbacks in 40%. Subjects responded with larger increases in plasma MHPG than controls. Yohimbine precipitated significant increases in all PTSD symptoms.

2) Corticosteroids. Two studies have shown that veterans with PTSD have low urinary cortisol excretion, even when they have comorbid major depressive disorder (42,53). One study failed to replicate this finding (49). In a series of studies, Yehuda et al (42,54) found increased numbers of lymphocyte glucocorticoid receptors in Vietnam veterans with PTSD. Interestingly, the number of glucocorticoid receptors was proportional to the severity of PTSD symptoms. Yehuda (54) also has reported the results of an unpublished study by Heidi Resnick, in which acute cortisol response to trauma was studied from blood samples from 20 acute rape victims. Three months later, a prior trauma history was taken, and the subjects were evaluated for the presence of PTSD. Victims with a prior history of sexual abuse were significantly more likely to have developed PTSD three months following the rape than rape victims who did not develop PTSD. Cortisol levels shortly after the rape were correlated with histories of prior assaults: the mean initial cortisol level of individuals with a prior assault history was 15 ug/dl compared to 30 ug/dl in individuals without. These findings can be interpreted to mean either that prior exposure to traumatic events result in a blunted cortisol response to subsequent trauma, or in a quicker return of cortisol to baseline following stress. The fact that Yehuda et al (45) also found subjects with PTSD to be hyperresponsive to low doses of dexamethasone argues for an enhanced sensitivity of the HPA feedback in traumatized patients.

3) Serotonin. While the role of serotonin in PTSD has not been systematically investigated, both the fact that inescapably shocked animals develop decreased CNS serotonin levels (55), and that serotonin re-uptake blockers are effective pharmacological agents in the treatment of PTSD, justify a brief consideration of the potential role of this neurotransmitter in PTSD. Decreased serotonin in humans has repeatedly been correlated with impulsivity and aggression (56,57,58). The literature tends to readily assume that these relationships are based on genetic traits. However, studies of impulsive, aggressive and suicidal patients seem to find at least as robust an association between those behaviors and histories of childhood trauma (e.g. 59,60,61). It is likely that both temperament and experience affect relative CNS serotonin levels (12).

Low serotonin in animals is also related to an inability to modulate arousal, as exemplified by an exaggerated startle (62,63), and increased arousal in response to novel stimuli, handling, or pain (63). The behavioral effects of serotonin depletion on animals is characterized by hyperirritability, hyperexitability, and hypersensitivity, and an "...exaggerated emotional arousal and/or aggressive display, to relatively mild stimuli" (63). These behaviors bear a striking resemblance to the phenomenology of PTSD in humans. Furthermore, serotonin re-uptake inhibitors have been found to be the most effective pharmacological treatment of both obsessive thinking in people with OCD (64), and of involuntary preoccupation with traumatic memories in people with PTSD (65,66). It is likely that serotonin plays a role in the capacity to monitor the environment flexibly and to respond with behaviors that are situation-appropriate, rather than reacting to internal stimuli that are irrelevant to current demands.

4). Endogenous opioids. Stress induced analgesia (SIA) has been described in experimental animals following a variety of inescapable stressors such as electric shock, fighting, starvation and cold water swim (67). In severely stressed animals, opiate withdrawal symptoms can be produced both by termination of the stressful stimulus or by naloxone injections. Stimulated by the findings that fear activates the secretion of endogenous opioid peptides, and that SIA can become conditioned to subsequent stressors and to previously neutral events associated with the noxious stimulus, we tested the hypothesis that in people with PTSD, re-exposure to a stimulus resembling the original trauma will cause an endogenous opioid response that can be indirectly measured as naloxone reversible analgesia (68,69). We found that two decades after the original trauma, people with PTSD developed opioid-mediated analgesia in response to a stimulus resembling the traumatic stressor, which we correlated with a secretion of endogenous opioids equivalent to 8 mg of morphine. Self-reports of emotional responses suggested that endogenous opioids were responsible for a relative blunting of the emotional response to the traumatic stimulus.
Endogenous Opiates & Stress Induced Analgesia: Possible Implications for Affective Function

When young animals are isolated, and older ones attacked, they respond initially with aggression (hyperarousal- fight- protest), and, if that does not produce the required results, with withdrawal (numbing-flight-despair). Fear-induced attack or protest patterns in the young serve to attract protection, and in mature animals to prevent or counteract the predator's activity. During external attacks pain-inhibition is a useful defensive capacity, because attention to pain would interfere with effective defense: grooming or licking wounds may attract opponents and stimulate further attack (70). Thus defensive and pain-motivated behaviors are mutually inhibitory. Stress-induced analgesia protects organisms against feeling pain while engaged in defensive activities. As early as 1946, Beecher (71), after observing that 75% of severely wounded soldiers on the Italian front did not request morphine, speculated that "strong emotions can block pain". Today, we can reasonably assume that this is due to the release of endogenous opioids(68,69).

Endogenous opioids, which inhibit pain and reduce panic, are secreted after prolonged exposure to severe stress. Siegfried et al (70) have observed that memory is impaired in animals when they can no longer actively influence the outcome of a threatening situation. They showed that both the freeze response and panic interfere with effective memory processing: excessive endogenous opioids and NE both interfere with the storage of experience in explicit memory. Freeze/numbing responses may serve the function of allowing organisms to not "consciously experience" or not to remember situations of overwhelming stress (and which thus will also keep them from learning from experience). We have proposed that the dissociative reactions in people in response to trauma may be analogous to this complex of behaviors that occur in animals after prolonged exposure to severe uncontrollable stress (68).
Developmental Level Affects the Psychobiological Effects of Trauma

While most studies on PTSD have been done on adults, particularly on war veterans, in recent years a small prospective literature is emerging that documents the differential effects of trauma at various age levels. Anxiety disorders, chronic hyperarousal, and behavioral disturbances have been regularly described in traumatized children (e.g.72,73,74). In addition to the reactions to discrete, one time, traumatic incidents documented in these studies, intrafamilial abuse is increasingly recognized to produce complex post-traumatic syndromes (75), which involve chronic affect dysregulation, destructive behavior against self and others, learning disablities, dissociative problems, somatization, and distortions in concepts about self and others (76,77). The Field Trials for DSM IV showed that these this conglomeration of symptoms tended to occur together and that the severity of this syndrome was proportional to the age of onset of the trauma and its duration (78).

While current research on traumatized children is outside the scope of this review, it is important to recognize that a range of neurobiological abnormalities are beginning to be identified in this population. Frank Putnam's prospective, but as yet unpublished, studies (personal communications, 1991,1992,1993) are showing major neuroendocrine disturbances in sexually abused girls compared with normals. Research on the psychobiology of childhood trauma can be profitably informed by the vast literature on the psychobiological effects of trauma and deprivation in non-human primates (12,79).
Trauma & Memory: The Flexibility of Memory & the Engraving of Trauma

One hundred years ago, Pierre Janet (1) suggested that the most fundamental of mental activities is the storage and categorization of incoming sensations into memory, and the retrieval of those memories under appropriate circumstances. He, like contemporary memory researchers, understood that what is now called semantic, or declarative, memory is an active and constructive process and that remembering depends on existing mental schemata (3,80): once an event or a particular bit of information is integrated into existing mental schemes, it will no longer be accessible as a separate, immutable entity, but be distorted both by prior experience, and by the emotional state at the time of recall(3). PTSD, by definition, is accompanied by memory disturbances, consisting of both hypermnesias and amnesias (9,10). Research into the nature of traumatic memories (3) indicates that trauma interferes with delarative memory, i.e. conscious recall of experience, but does not inhibit implicit, or non-declarative memory, the memory system that controls conditioned emotional responses, skills and habits, and sensorimotor sensations related to experience. There now is enough information available about the biology of memory storage and retrieval to start building coherent hypotheses regarding the underlying psychobiological processes involved in these memory disturbances (3,16,17,25).

In the beginning of this century Janet already noted that: "certain happenings ... leave indelible and distressing memories-- memories to which the sufferer continually returns, and by which he is tormented by day and by night" (81). Clinicians and researchers dealing with traumatized patients have repeatedly made the observation that the sensory experiences and visual images related to the trauma seem not to fade over time, and appear to be less subject to distortion than ordinary experiences (1,49,82). When people are traumatized, they are said to experience "speechless terror": the emotional impact of the event may interfere with the capacity to capture the experience in words or symbols. Piaget (83) thought that under such circumstances, failure of semantic memory leads to the organization of memory on a somatosensory or iconic level (such as somatic sensations, behavioral enactments, nightmares and flashbacks). He pointed out: "It is precisely because there is no immediate accommodation that there is complete dissociation of the inner activity from the external world. As the external world is solely represented by images, it is assimilated without resistance (i.e. unattached to other memories) to the unconscious ego".
Traumatic memories are state dependent.

Research has shown that, under ordinary conditions, many traumatized people, including rape victims (84), battered women (85) and abused children (86) have a fairly good psychosocial adjustment. However, they do not respond to stress the way other people do. Under pressure, they may feel, or act as if they were traumatized all over again. Thus, high states of arousal seem to selectively promote retrieval of traumatic memories, sensory information, or behaviors associated with prior traumatic experiences (9,10). The tendency of traumatized organisms to revert to irrelevant emergency behaviors in response to minor stress has been well documented in animals, as well. Studies at the Wisconsin primate laboratory have shown that rhesus monkeys with histories of severe early maternal deprivation display marked withdrawal or aggression in response to emotional or physical stimuli (such as exposure to loud noises, or the administration of amphetamines), even after a long period of good social adjustment (87). In experiments with mice, Mitchell and his colleagues (88) found that the relative degree of arousal interacts with prior exposure to high stress to determine how an animal will react to novel stimuli. In a state of low arousal, animals tend to be curious and seek novelty. During high arousal, they are frightened, avoid novelty, and perseverate in familiar behavior, regardless of the outcome. Under ordinary circumstances, an animal will choose the most pleasant of two alternatives. When hyperaroused, it will seek whatever is familiar, regardless of the intrinsic rewards. Thus, animals who have been locked in a box in which they were exposed to electric shocks and then released return to those boxes when they are subsequently stressed. Mitchell concluded that this perseveration is nonassociative, i.e. uncoupled from the usual reward systems.

In people, analogous phenomena have been documented: memories (somatic or symbolic) related to the trauma are elicited by heightened arousal (89). Information acquired in an aroused, or otherwise altered state of mind is retrieved more readily when people are brought back to that particular state of mind (90,91). State dependent memory retrieval may also be involved in dissociative phenomena in which traumatized persons may be wholly or partially amnestic for memories or behaviors enacted while in altered states of mind (2,3,92).

Contemporary biological researchers have shown that medications that stimulate autonomic arousal may precipitate visual images and affect states associated with prior traumatic experiences in people with PTSD, but not in controls. In patients with PTSD the injection of drugs such as lactate (93) and yohimbine (52) tends to precipitate panic attacks, flashbacks (exact reliving experiences) of earlier trauma, or both. In our own laboratory, approximately 20% of PTSD subjects responded with a flashback of a traumatic experience when they were presented with acoustic startle stimuli.
Trauma, neurohormones and memory consolidation.

When people are under severe stress, they secrete endogenous stress hormones that affect the strength of memory consolidation. Based on animal models it has been widely assumed (3,46,94) that massive secretion of neurohormones at the time of the trauma plays a role in the long term potentiation (LTP) (and thus, the over- consolidation) of traumatic memories. Mammals seem equipped with memory storage mechanisms that ordinarily modulate the strength of memory consolidation according to the strength of the accompanying hormonal stimulation (95,96). This capacity helps the organism evaluate the importance of subsequent sensory input according to the relative strength of associated memory traces. This phenomenon appears to be largely mediated by NE input to the amygdala (97,98, figure 2). In traumatized organisms, the capacity to access relevant memories appears to have gone awry: they become overconditioned to access memory traces of the trauma and to "remember" the trauma whenever aroused. While norepinephrine (NE) seems to be the principal hormone involved in producing LTP, other neurohormones secreted under particular stressful circumstances, such as endorphins and oxytocin, actually inhibit memory consolidation (99).

The role of NE in memory consolidation has been shown to have an inverted U-shaped function (95,96): both very low and very high levels of CNS NE activity interfere with memory storage. Excessive NE release at the time of the trauma, as well as the release of other neurohormones, such as endogenous opioids, oxytocin and vasopressin, are likely to play a role in creating the hypermnesias and the amnesias that are a quintessential part of PTSD (9,10). It is of interest that childbirth, which can be extraordinarily stressful, almost never seems to result in post traumatic problems (100). Oxytocin may play a protective role that prevents the overconsolidation of memories surrounding childbirth.

Physiological arousal in general can trigger trauma-related memories, while, conversely, trauma-related memories precipitate generalized physiological arousal. It is likely that the frequent re-living of a traumatic event in flashbacks or nightmares cause a re-release of stress hormones which further kindle the strength of the memory trace (46). Such a positive feedback loop could cause subclinical PTSD to escalate into clinical PTSD (16), in which the strength of the memories appear so deeply engraved that Pitman and Orr (17) have called it "the Black Hole" in the mental life of the PTSD patient, that attracts all associations to it, and saps current life of its significance.
Memory, Trauma & the Limbic System

The limbic system is thought to be the part of the CNS that maintains and guides the emotions and behavior necessary for self-preservation and survival of the species (101), and that is critically involved in the storage and retrieval of memory. During both waking and sleeping states signals from the sensory organs continuously travel to the thalamus whence they are distributed to the cortex (setting up a "stream of thought"), to the basal ganglia (setting up a "stream of movement") and to the limbic system where they set up a "stream of emotions"(102), that determine the emotional significance of the sensory input. It appears that most processing of sensory input occurs outside of conscious awareness, and only novel, significant or threatening information is selectively passed on to the neocortex for further attention. Since people with PTSD appear to over-interpret sensory input as a recurrence of past trauma and since recent studies have suggested limbic system abnormalities in brain imaging studies of traumatized patients (103,104), a review of the psychobiology of trauma would be incomplete without considering the role of the limbic system in PTSD (also see 105). Two particular areas of the limbic system have been implicated in the processing of emotionally charged memories: the amygdala and the hippocampus (Table 2).

The amygdala. Of all areas in the CNS, the amygdala is most clearly implicated in the evaluation of the emotional meaning of incoming stimuli (106). Several investigators have proposed that the amygdala assigns free-floating feelings of significance to sensory input, which the neocortex then further elaborates and imbues with personal meaning (101,106,107,108). Moreover, it is thought to integrate internal representations of the external world in the form of memory images with emotional experiences associated with those memories (80). After assigning meaning to sensory information, the amygdala guides emotional behavior by projections to the hypothalamus, hippocampus and basal forebrain (106,107,109).

The septo-hippocampal system, which anatomically is adjacent to the amygdala, is thought to record in memory the spatial and temporal dimensions of experience and to play an important role in the categorization and storage of incoming stimuli in memory. Proper functioning of the hippocampus is necessary for explicit or declarative memory (109). The hippocampus is thought to be involved in the evaluation of spatially and temporally unrelated events, comparing them with previously stored information and determining whether and how they are associated with each other, with reward, punishment, novelty or non-reward (107,110). The hippocampus is also implicated in playing a role in the inhibition of exploratory behavior and in obsessional thinking, while hippocampal damage is associated with hyper-responsiveness to environmental stimuli (111,112).

The slow maturation of the hippocampus, which is not fully myelinated till after the third or fourth year of life, is seen as the cause of infantile amnesia (113,114). In contrast, it is thought that the memory system that subserves the affective quality of experience (roughly speaking procedural, or "taxon" memory) matures earlier and is less subject to disruption by stress (112).

As the CNS matures, memory storage shifts from primarily sensorimotor (motoric action) and perceptual representations (iconic), to symbolic and linguistic modes of organization of mental experience (83). With maturation, there is an increasing ability to categorize experience, and link it with existing mental schemes. However, even as the organism matures, this capacity, and with it, the hippocampal localization system, remains vulnerable to disruption (45,107,110,115,116). A variety of external and internal stimuli, such as stress induced corticosterone production (117), decreases hippocampal activity. However, even when stress interferes with hippocampally mediated memory storage and categorization, it is likely that some mental representation of the experience is laid down by means of a system that records affective experience, but that has no capacity for symbolic processing and placement in space and time (figure 2).

Decreased hippocampal functioning causes behavioral disinhibition, possibly by stimulating incoming stimuli to be interpreted in the direction of "emergency" (fight/flight) responses. The neurotransmitter serotonin plays a crucial role in the capacity of the septo-hippocampal system to activate inhibitory pathways that prevent the initiation of emergency responses until it is clear that they will be of use (110). This observation made us very interested in a possible role for serotonergic agents in the treatment of PTSD.
"Emotional memories are forever"

In animals, high level stimulation of the amygdala interferes with hippocampal functioning (107, 109). This implies that intense affect may inhibit proper evaluation and categorization of experience. In mature animals one-time intense stimulation of the amygdala will produce lasting changes in neuronal excitability and enduring behavioral changes in the direction of either fight or flight (118). In kindling experiments with animals, Adamec et al (119) have shown that, following growth in amplitude of amygdala and hippocampal seizure activity, permanent changes in limbic physiology cause a lasting changes in defensiveness and in predatory aggression. Pre-existing "personality" played a significant role in the behavioral effects of amygdala stimulation in cats: animals that are temperamentally insensitive to threat and prone to attack tend become more aggressive, while in highly defensive animals different pathways were activated, increasing behavioral inhibition (119).

In a series of experiments, LeDoux has utilized repeated electrical stimulation of the amygdala to produce conditioned fear responses. He found that cortical lesions prevent their extinction. This led him to conclude that, once formed, the subcortical traces of the conditioned fear response are indelible, and that "emotional memory may be forever" (118). In 1987, Lawrence Kolb (29) postulated that patients with PTSD suffer from impaired cortical control over subcortical areas responsible for learning, habituation, and stimulus discrimination. The concept of indelible subcortical emotional responses, held in check to varying degrees by cortical and septo-hippocampal activity, has led to the speculation that delayed onset PTSD may be the expression of subcortically mediated emotional responses that escape cortical, and possibly hippocampal, inhibitory control (3,16,94,120,121).

Decreased inhibitory control may occur under a variety of circumstances: under the influence of drugs and alcohol, during sleep (as nightmares), with aging, and after exposure to strong reminders of the traumatic past. It is conceivable that traumatic memories then could emerge, not in the distorted fashion of ordinary recall, but as affect states, somatic sensations or as visual images (nightmares [81] or flashbacks [52]) that are timeless and unmodified by further experience.
Psychopharmacological Treatment

The goal of treatment of PTSD is to help people live in the present, without feeling or behaving according to irrelevant demands belonging to the past. Psychologically, this means that traumatic experiences need to be located in time and place and distinguished from current reality. However, hyperarousal, intrusive reliving, numbing and dissociation get in the way of separating current reality from past trauma. Hence, medications that affect these PTSD symptoms are often essential for patients to begin to achieve a sense of safety and perspective from which to approach their tasks. While numerous articles have been written about the drug treatment of PTSD, to date, only 134 people with PTSD have been enrolledin published double blind studies. Most of these have been Vietnamcombat veterans. Unfortunately, up until recently, only medications which seem to be of limited therapeutic usefulness have beenthesubject of adequate scientific scrutiny. While the only published double blind studies of medications in the treatment of PTSDhave been tricyclic antidepressants and MAO Inhibitors (122,123,124), it is sometimes assumed that they therefore also are themosteffective. Three double-blind trials of tricyclic antidepressants have been published (122,124,125), two of which demonstrated modest improvement in PTSD symptoms. While positive resultshave been claimed for numerous other medications in case reportsand open studies, at the present time there are no data aboutwhich patient and which PTSD symptom will predictably respond toanyof them. Success has been claimed for just about every class ofpsychoactive medication, including benzodiazepines (127), tricyclic antidepressants (122,125), monamine oxidase inhibitors (122,129) lithium carbonate (127), beta adrenergic blockers and clonidine (130), carbamezapine (131) and antipsychotic agents. The accumulated clinical experience seems to indicate that understanding thebasic neurobiology of arousal and appraisal is the most useful guideinselecting medications for people with PTSD (124,125). Autonomic arousal can be reduced at different levels in the CNS: throughinhibition of locus coeruleus noradrenergic activity with clonidine and the beta adrenergic blockers (130,132), or by increasing the inhibitory effect of the gaba-ergic system with gaba- ergicagonists (the benzodiazepines). During the past two years a numberof case reports and open clinical trials of fluoxetine were followedby our double blind study of 64 PTSD subjects with fluoxetine (65). Unlike the tricyclic antidepressants, which were effective on either the intrusive (imipramine) or numbing (amitryptiline) symptoms of PTSD, fluoxetine proved to be effective forthewhole spectrum of PTSD symptoms. It also acted more rapidly thanthetricyclics. The fact that fluoxetine has proven to be such aneffective treatment for PTSD supports a larger role of the serotonergic system in PTSD (66). Rorschach tests adminstered by blindscorers revealed that subjects on fluoxetine became able to takedistance from the emotional impact of incoming stimuli and to becomeable to utilize cognition to harness the emotional responses tounstructured visual stimuli (van der Kolk et al, unpublished).

While the subjects improved clinically, their startle habituation got worse (van der Kolk et al, unpublished). The 5-HT1a agonist buspirone shows some promise in facilitating habituation (133) and thus may play a useful adjunctive role in the pharmaco- therapy of PTSD. Even newer research has suggested abnormalities of the N-methyl-D-aspartate (NMDA) receptor and of glutamate in PTSD (134), opening up potential new avenues for the psychopharmacological treatment of PTSD.

Labels: , , , , ,

Monday, October 1, 2007

"Afibbers" pdf file of discussion about minerals

Can You Hang on to Magnesium? For magnesium to get into cells it requires thiamine (vitamin B1). Try thiamine 100mgs daily – if you are already taking some in a multivitamin preparation, then take the B1 at 100mg a day. For magnesium to be retained inside cells you need good antioxidant status. Selenium is the main mineral antioxidant. Food tables are unreliable because food content is dependent on soil levels of selenium. Assuming good soil levels, (which is a big assumption), foods rich in selenium include wholegrains, organ meats, butter, garlic and onion. Seafoods are rich in selenium and obviously not dependent on soil levels. Boron is necessary for normal calcium and magnesium metabolism. I also find boron very useful for arthritis, perhaps because of its effect on calcium and magnesium. For arthritis you need 9mgs a day for 3 months, then reduce to a maintenance dose of 3-6mgs daily. At present the only way I know how to ascertain whether or not magnesium levels are replete is to measure a red cell magnesium. http://www.immunesupport.com/library/showarticle.cfm/id/2892 Richard Boron may not be advantageous for Mg. as stated above, or the site above could be altogether wrong. Boron and its involvement with attention deficit disorder is a concept that appears not to have been considered before. Boron, phenols and/or histamine may possibly cause thinning of the middle part of the brain where nerve fibres cross over. This part of the brain is called the corpus callosum. Damage to this area (prior to birth) causes learning disabilities. Boron increases copper in the body. High copper levels cause reductions in thiamine (vitamin B1). Lack of thiamine causes many problems associated with ADD. A lack of this vitamin reduces oxygen supply to the brain. Low cholinesterase levels are associated with a thiamine deficiency. Lack of thiamine may indirectly lower the neurotransmitter dopamine. There are below normal dopamine levels in hyperactive children. Low cholinesterase levels are sometimes associated with asthma. Boron interferes with the metabolism of phenols. Phenylalanine (a phenol) is able to reduce serotonin levels. Serotonin levels are reduced in children with ADD. The medication Ritalin used in the treatment of ADD inhibits the metabolism of coumarins (phenols). Low and high histamine levels are also discussed. Boron reduces pyridoxine (vitamin B6) levels in the body. The importance of this occurrence to the reduction of the symptoms of ADD is covered throughout the book. A brief description of how boron interacts with body nutrients is discussed. Boron has the ability to cause an excess or depletion of vital substances. This causes a spin off in alteration of other nutrients. For example, boron has an indirect effect of reducing zinc levels in the body. Boron increases calcium retention in the body. Calcium reduces zinc. As outlined in this book, boron plays a role in excreting pyridoxine (vitamin B6) from the body. Vitamin B6 is necessary for zinc absorption. Vitamin B6 and zinc play major roles in neurotransmitter function. Neurotransmitters are chemicals that relay messages between nerves in the body. Some neurotransmitters have a relaxing effect whilst others have a stimulatory effect. An imbalance of neurotransmitters (as discussed throughout this book) may cause symptoms of ADHD/ADD. Nausea during pregnancy is associated with a deficiency of vitamin B6 (pyridoxine) and zinc. Acute toxicity of boron presents with nausea, vomiting, lethargy, dermatitis and diarrhoea. ADD is possibly linked to the food the mother consumed during pregnancy. A diet (during pregnancy) giving a high intake of boron containing foods together with a high intake of calcium containing foods may be a contributing factor to the ADD symptoms of the child. Water supplies containing high levels of calcium and/or copper reduce zinc absorption in the body. Boron is found in apples, pears, grapes, nuts, leafy green vegetables and legumes. My levels of copper were high, and zinc was low. My hair analysis of Boron was fairly normal, but just a tad to the low side. Hmmmmm????? So is my problem more that I need B1 to absorb the Mg. Questions to ask Dr. Gersten.

Labels: , , , , , , , , , ,

Saturday, September 8, 2007

EFAs and behavior

What are EFAs? · Nutrition: Essential Fatty Acids (EFAs): What are EFAs? Things to Avoid · Nutrition: Essential Fatty Acids (EFAs): Things to Avoid Omega-3 Deficiency Symptoms List of Symptoms "These signs include · dry hair, · dry skin (often noticed as a 'goosebump' rash on the upper arms and/or upper thighs), · excessive thirst, · frequent urination, · problems with attention and so on." ILT: Essential Fatty Acids (EFAs) Keratosis Pilaris Keratosis Pilaris: Definition "Keratosis pilaris is a common skin condition that looks like small goose bumps, which are actually dead skin cells that build up around the hair follicle." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Description · "Keratosis pilaris is a disorder that occurs around the hair follicles of the upper arms, thighs, and sometimes the buttocks. · It presents as small, benign bumps or papules that are actually waxy build-ups of keratin. Normally skin sloughs off. However, around the hair follicle where the papules form, the keratinized skin cells slough off at a slower rate, clogging the follicles. · This is generally thought to be genetic disorder, although the symptoms of keratosis pilaris are often seen with ichthyosis and allergic dermatitis. It can also be observed in people of all ages who have either inherited it or have a vitamin A deficiency or have dry skin. · Keratosis pilaris is a self-limiting disorder that disappears as the person ages. · It can become more severe when conditions are dry such as during the winter months or in dry climates." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Causes and Symptoms "The specific causes of this disorder are unknown. Since this disorder runs in families, it is thought to be hereditary. Keratosis pilaris is not a serious disorder and is not contagious. The symptoms of keratosis pilaris are based on the development of small white papules the size of a grain of sand on the upper arms, thighs, and occasionally the buttocks and face. The papules occur around a hair follicle and are firm and white. They feel a little like coarse sandpaper, but they are not painful and there usually is no itching associated with them. They are easily removed and the material inside the papule usually contains a small, coiled hair." HealthAtoZ.com: Keratosis Pilaris Keratosis Pilaris: Treatment · "To treat keratosis pilaris patients can try several strategies to lessen the bumps. · First, the patient can supplement the natural removal of dry skin and papules by using a loofah or another type of scrub showering or bathing. · A variety of different over-the-counter (OTC) lotions, ointments, and creams can also be applied after showering while the skin is still moist and then several times a day to keep the area moist. · Medicated lotions with urea, 15% alphahydroxy acids, or Retin A can also be prescribed by the dermatologist and applied one to two times daily. · Systemic (oral) medications are not prescribed for keratosis pilaris. · However if papules are opened and become infected, antibiotics may be necessary to treat the infection." HealthAtoZ.com: Keratosis Pilaris "I did a little research on vitamin a deficiency and it seems to be, if not a cause, then a trigger to a lot of skin problems. However, taking vitamin A does not necessarily eliminate the deficiency. I know this because I was taking a vitamin A/B combo and nothing was happening. Then after doing some reading about eczema…omega 3 fatty acids (found in cod liver oil supplements [caution: cod liver oil in the quantity necessary to get three grams per day of omega-3's would contain dangerous levels of vitamin A]) help the body absorb vitamin A. This has worked for me and has offset a lot of the uncomfortable dry skin associated with not only my eczema, but also on my arms and legs (KP)." KeratosisPilaris.org: Archives: Re: Vitamin A and KP · Essential Fatty Acids (EFAs): Things to Avoid: Too Much Fish, Farm-Raised Fish · Essential Fatty Acids (EFAs): Things to Avoid: Dangerous Levels of Vitamin A · Nutrition: Vitamins and Minerals: Liquid Multivitamins: Absorption · Nutrition: Vitamins and Minerals: Vitamin A: Absorption Effects ADD, Dyslexia "If a child does not get enough EFAs, the myelin sheath protecting the axons of billions of neurons may not be adequate. Recent research is showing that boys with ADD have EFA deficiencies (Stevens, L. et al, 1995:000-000) and similar deficiencies are possibly responsible for the symptoms of dyslexia. (Stordy & Nicholl, 2000:105)." ILT: Essential Fatty Acids (EFAs) Depression "When researchers monitor eating habits across countries, they find that as fish consumption goes up, depression rates go down. In fact, there is a sixty-fold difference in depression rates across countries from the highest (Japan and Taiwan) to the lowest (North America, Europe and New Zealand) omega-3 fat consumption. Even postpartum depression decreases as women increase their consumption of fish. Many people also report a drop in mood when they switch too quickly to a low-fat diet. (Page 156)" Book: Somer, Elizabeth, M.A., R.D. Food & Mood. Henry Holt and Company, LLC, 1999. Serotonin and Dopamine "Over the last decade, neuroscientists have been examining the consequences of omega-3 deficiencies in the central nervous system. Alterations in serotonin and dopamine levels, as well as the functioning of these two important neurotransmitters is evident in an omega-3 deficiency. The changes observed in omega-3 deficiency in animals is strikingly similar to that found in autopsy studies of human depression.20" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Blood-Brain Barrier "In addition to changing serotonin and dopamine levels and functioning, omega-3 deficiencies are known to compromise the blood-brain barrier, which normally protects the brain from unwanted matter gaining access.21" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Blood Flow "Omega-3 deficiency can also decrease normal blood flow to the brain,22,23 an interesting finding given the studies which show that patients with depression have compromised blood flow to a number of brain regions.24,25" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Antidepressant Activity "Finally, omega-3 deficiency also causes a 35 percent reduction in brain phosphatidylserine (PS) levels.26 This is also of relevance when considering that PS has documented antidepressant activity in humans.27,28" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Mechanisms of EPA/DHA Regulation of Mood "DHA [an omega-3 fatty acid] is found in high levels in the cells of the central nervous system (neurons); here it acts as a form of scaffolding for structural support.29 When omega-3 intake is inadequate, the nerve cell becomes stiff as cholesterol and omega-6 fatty acids are substituted for omega-3.30 When a nerve cell becomes rigid, proper neurotransmission from cell to cell and within cells will be compromised.31 While DHA provides structure and helps to ensure normal neurotransmission, EPA [an omega-3 fatty acid] may be more important in the signaling within nerve cells.32 Normalizing communications within nerve cells has been suggested to be an important factor in alleviating depressive symptoms.33" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "In addition, EPA can lower the levels of two important immune chemicals, · tumour necrosis factor alpha (TNFa) and · interleukin 1 beta (IL-1ß), · as well as prostaglandin E2.34 All three of these chemicals are elevated in depression.35-38 In fact, higher levels of TNFa and IL-1ß are associated with severity of depression.39" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "Finally, EPA has been hypothesized to increase brain-derived neurotropic factor (BDNF), which is known to be lower in depressed patients.20 BDNF is neuroprotective, enhances neurotransmission, has antidepressant activity and supports normal brain structure. BDNF may prevent the death of nerve cells in depression." New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Correcting an Omega-3 Deficiency Note: More information about sources of omega-3s can be found on the page Nutrition: Essential Fatty Acid (EFA) Sources Flax "Flax, our richest source of omega 3, quickly replenishes a long-standing omega 3 deficiency. A dozen 8 oz. bottles of good quality flax oil consumed over the course of a few months will suffice [approximately one bottle every five days, 1.6 ounces per day]." The Edelson Center: Essential Fatty Acids: The Healing Fats "There have been some published case reports indicating that flaxseed oil may be helpful in cases of bipolar depression and the anxiety disorder agoraphobia.40 The first controlled clinical trial indicating that omega-3 fatty acids may be of benefit in depression was published in 1999. In this case, 9:6 g ['9:6 g' should be read a dose of 6 g per day for a period of nine days?] of EPA/DHA versus placebo led to longer periods of remission and improvement in depressive symptoms in those with bipolar depression.41" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 2g Daily of Pure EPA "Some researchers theorize that such high doses of EPA/DHA may not be necessary and that low levels of pure EPA may be of benefit.32 In a study published in the American Journal of Psychiatry, researchers showed that just 2g of pure EPA could improve the symptoms of treatment-resistant depression. The researchers found that the EPA (versus placebo), when added to an ineffective antidepressant for one month, significantly improved depressive symptoms.42" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 1g Daily of Pure EPA "A larger study published in Archives of General Psychiatry replicated these findings, however, this time various doses of EPA were examined. Those on ineffective antidepressants were given 1g, 2g or 4g of pure EPA or a placebo in addition to the medication. Interestingly, the 1g daily dose of EPA led to the most significant improvements over the three-month study; it appeared that less was more. There were significant improvements in depressive symptoms, sleep, anxiety, lassitude, libido and thoughts of suicide.43" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH "Harvard researchers have also shown that just 1g of pure EPA is beneficial in the treatment of borderline personality disorder. This personality disorder, which is particularly difficult to treat, is characterized by both depressive and aggressive symptoms. This was a two-month placebo-controlled study and the results showed that EPA has a mood-regulating effect, improving both depression and aggression versus placebo.46" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH 4.4g EPA and 2.2g DHA Mix "Researchers from Taiwan Medical University published a recent study in which they found that a 4.4g EPA and 2.2g DHA mix could alleviate depression versus placebo in those with treatment-resistant depression. This was a two-month study involving patients who were on antidepressants that were not working. As with the other omega-3 studies discussed, the fish oil was well tolerated and no adverse events were reported.44" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Antarctic Krill Oil (400mg EPA, 240mg DHA) "There is also evidence that omega-3 oils may be of benefit in treating depressive symptoms outside of major depressive disorder. Canadian researchers showed that Antarctic krill oil (400mg EPA, 240mg DHA) could improve depressive symptoms associated with premenstrual syndrome.45" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH DHA Alone not Recommended "To date, with one exception, all studies conducted on omega-3 fatty acids and mood have had a positive outcome. The singular negative study examined pure DHA in patients with depression. The results in the case showed that DHA alone was no better than placebo in alleviating depressive symptoms.47" New Findings About Omega-3 Fatty Acids and Depression by Alan C. Logan, ND, FRSH Omega-6 Deficiency "Long--term exclusion or excessive use of flax oil can result in omega 6 deficiency after about two years, because flax oil is omega 3 rich but omega 6 poor." The Edelson Center: Essential Fatty Acids: The Healing Fats

Labels: , , , , ,

Thursday, August 30, 2007

Supplements for ADHD

ADD & ADHD ADD & ADHD Natural Control of ADD & ADHD Billie J. Sahley, Ph.D., CNC In Toxic Psychiatry, Peter Breggin, MD states, Hyperactivity is the most frequent justification for drugging children. Difficult-to-control children are certainly not a new phenomenon, but attempts to give them a medical diagnosis are the product of modern psychology and psychiatry. At first, psychiatrists called hyperactivity a brain disease: minimal brain dysfunction (MBD). When no minimal brain dysfunction could be demonstrated, the label became attention deficit disorder (ADD). Six million children in this country suffer some type of learning disability, ADD, or ADD with hyperactivity (ADHD). Over two million children currently take Ritalin for ADD/ADHD. ADD and ADHD may be caused by psychological problems, including trauma and abuse, nutritional deficiencies, chemical imbalances, allergic responses to food and chemicals, or a poor diet. A failure in the brains inhibitory system (the ability of the brain to inhibit and control itself) may also cause ADD/ADHD. Ritalin, the most commonly used drug for ADD and ADHD, is an amphetamine and a Schedule II class drug (other Schedule II drugs are morphine, opium, and medicinal cocaine). Doctors prescribe Ritalin for many children who do not need it, causing a number of adverse mental and physical side effects. Yet this potent, toxic drug is being used as a quick fix to quiet children. Surprisingly, prescription rates for Ritalin doubled between 1992 and 1996. Children demonstrating symptoms of anxiety, ADHD or ADD often have an imbalance in their brains biochemistry. A biochemical imbalance results from a deficiency of neurotransmitters, the chemical messengers of the brain. If a biochemical imbalance goes untreated, a child can display maladaptive behavior, followed by possible long-term physical and emotional problems. A childs state of health reflects his or her state of nutrition. When minerals, vitamins, amino acids, enzymes, or even hormones are deficient in a childs system, the result can be a disturbed biochemical homeostasis causing impaired functions in the brain. This, in turn, can cause an inability to focus, concentrate, and stay on task. At the Pain and Stress Center in San Antonio, we have successfully treated numerous children with orthomolecular therapy. Orthomolecular therapy corrects the brains biochemical imbalance, without toxic drugs that can produce adverse side effects. ADD/ADHD presents a major problem facing parents today. Most people think of hyperactivity as some type of behavioral problem (a child who is impatient, impulsive, and constantly moving); but not all hyperactive children are aggressive. Some are very passive, withdrawn, and find it hard to communicate their feelings. ADD/ADHD is not a condition that can be measured in precise scientific terms. Nor is it a situation with a quick fix, especially with powerful and addictive drugs such as Ritalin. ADD/ADHD is a complex and intricate condition in which children demonstrate maladaptive or disorganized behaviors, which put them out of sync with the world around them. Numerous clinical studies established that hyperactive children often have low serotonin levels. A proper combination of tryptophan or 5-HTP and B6, elevates the serotonin level and balances the brain; the childs symptoms diminish. The dosage, of course, depends on the childs age, weight, and the degree of hyperactivity. Effectiveness of Amino Acids Neurotransmitters affect behavior and learning. A neurotransmitter deficiency consequently has a dramatic effect on childrens or adults abilities to learn and function in an orderly manner. Most hyperactive and ADD children are born with a shortage of neurotransmitters, establishing a genetic link, most often on the male side. These children also do not manufacture the needed amount of these chemical messengers. Where do we get neurotransmitters? From the amino acids, GABA, glycine, taurine, tyrosine, glutamine and tryptophan. Do children or adults get enough aminos through diet? NO! Balanced amino-acid doses, in the right combination and formulas, produce the needed neurotransmitters naturally. Using a stimulant medication to try to produce neurotransmitters is like a shotgun going off in the childs brain. Our children were not born with Ritalin in their brain, so how can they have a Ritalin deficiency? Approximately fifty different neurotransmitters exist in the human brain, but communication between brain cells uses only ten (approximately) major neurotransmitters. How we feed the brain directly affects our production of neurotransmitters. With proper nutrition and supplementation, we can correct or enhance mind, mood, memory, and behavior. All major neurotransmitters are made from amino acids and dietary protein. One of the dangers of a low-protein diet is not ingesting enough amino acids to make adequate brain neurotransmitters. Apathy, lethargy, difficulty concentrating, loss of interest, and insomnia all result when the diet does not include adequate amounts of amino acids. Drugs do not produce or increase production of neurotransmitters. Drugs only address symptoms. Amino acids restore the balance nature intended. Some of the major symptoms of neurotransmitter deficiencies are ADD, ADHD, brain fog, mood swings, increased stress, anxiety, depression, insomnia, irritability, and aggression. Stress plays a major role in the depletion of neurotransmitters. Inhibitory neurotransmitters are the keys to behavior, emotions, and pain. Inhibitory amino acids include tryptophan, taurine, GABA, and glycine. Millions of people have turned to drugs known as SSRIs (Selective Serotonin Reuptake Inhibitors). These drugs, such as Prozac, Paxil, Zoloft, and Effexor work by selective enhancement of serotonin levels. SSRIs prevent the presynaptic nerve from reabsorbing serotonin that it previously secreted. Prozac causes an increase in brain serotonin levels; but Prozac and other prescription drugs do not increase neurotransmitters. (See Figure 1). 5-HTP is synergistic with other supplements that enhance neurotransmitters such as GABA, glutamine, tyrosine, phenylalanine, and glycine. Magnesium prolongs the benefits of 5-HTP. Chronic stress depletes available serotonin, as well as interferes with serotonins ability to control behavior. Research demonstrates that low serotonin levels can change brain function and impair learning. Low serotonin may be responsible for an increase in depression and drug use among teens and children. Most teens with low serotonin levels are more prone to try recreational drugs or even prescription drugs, for relief. A low brain serotonin level impairs the ability to focus and reason. 5-HTP shows a lot of promise as a natural answer to a multitude of problems that plague adults and children. Use caution with 5-HTP if your child is taking prescription antidepressant medications. GABA (Gamma-aminobutyric acid) GABA, an inhibitory neurotransmitter, is found throughout the central nervous system. GABA assumes an ever-enlarging role as a significant influence on ADD, ADHD, stress, anxiety, and depression, as well as stress-induced illnesses. According to Candace Pert, a neuroscientist who discovered the GABA receptor, every cell in the body has a GABA receptor, which is one reason why GABA has such positive effects. GABA inhibits the cells from firing, diminishing anxiety-related messages. Tranquilizers provide only temporary relief. We have seen many patients on Xanax that still experience anxiety. They have been told it is not addictive: it is! THERE IS NO SUCH THING AS A TRANQUILIZER DEFICIENCY! Nutrient deficiencies do occur, however; and they can and do change behavior. GABA, glutamine, and glycine prove vital for energy and the smooth running of brain functions. We have successfully used these three amino acids with patients to ease anxiety, irritability, and ADD. Research demonstrates a large number of children who display ADD/ADHD behavior actually experience anxiety. If they use all available GABA, then the receptors in the brain become empty, allowing the brain to be bombarded with random firings of excitatory messages. However, when adequate amounts of GABA are present, the reception of multiple random firings are blocked, so the brain does not become overwhelmed. At the Pain & Stress Center we regularly combine GABA and other amino acids to achieve positive results. Dose amounts vary, depending on the age and weight of the child. GABA now takes its place as a major influence on those taking drugs, and in many cases, replacing the drugs. We have found that, when combined with other amino acids, GABA works exceptionally well with ADD children. L-Glutamine Glutamine, along with GABA and Glycine, is rapidly becoming an important therapeutic amino acid of the 21st century. Glutamine, found in many foods, is the third most abundant amino acid in the blood and brain. It also provides a major alternative fuel source for the brain when blood sugar levels are low. Glutamine functions as an inhibitory neurotransmitter, and is the precursor for GABA, the antianxiety amino acid. The amino acid trio of Glutamine, GABA, and Glycine plus B6 are among the major inhibitory neurotransmitters in the brain. Glutamine is found in the nerves of the hippocampus, the memory center of the brain, in the cranial nerves, and in many other areas of the brain. These three amino acids work together as inhibitory neurotransmitters. Anyone taking amino acids must take B6 to metabolize the amino acids. Intellectually impaired children and adults often show an increase in IQ after taking glutamine in combination with Ginkgo biloba and B6. Dr. Roger Williams demonstrated that children and adults diagnosed with ADHD showed a marked improvement when taking 250 mg to 1,000 mg of glutamine daily. GABA and glutamine are not only found in the brain, but also in the receptor sites throughout the body. Glutamine is the memory and concentration amino acid. Seventy five percent of hyperactive and ADD childrens blood tests showed low levels of glutamine. Dr. C. Fredericks research also demonstrated a definite increase in the IQs of children given glutamine. When glutamine was given daily, children showed impressive improvements in their abilities to learn, to retain, and to recall. Glutamine is a major part of my orthomolecular program for hyperactive and ADHD children. Glutamine is one of the amino acids that create the neurotransmitters in the brain that enhance learning and memory. Hyperactive and ADD children have low neurotransmitter levels, especially glutamine. Adding glutamine increases the level of neurotransmitters. Start with 500 mg of glutamine and gradually increase until you reach the optimal dose for your child, to a maximum of 3,000 mg per day. Taurine Taurine is now classified as a conditionally essential amino acid in the adult. In infants and children, however, taurine is an essential amino acid. As one of the sulfur amino acids, adults synthesize taurine from cysteine and methionine, provided B6 and zinc are present. Taurine is found abundantly throughout the body in the heart, olfactory bulb, central nervous system, and brain (hippocampus and pineal gland). As an inhibitory neurotransmitter, taurine, after GABA, is the second-most important inhibitory transmitter in the brain. Taurines inhibitory action in the brain equals that of GABA and glycine. Its inhibitory effect is one source of taurines anticonvulsant and antianxiety properties. Some children with Downs syndrome have shown an increase in IQ levels when taurine was added to their diet along with glutamine, B6, and vitamin E. The need for taurine increases whenever you experience more stress than usual, or have an illness. Tyrosine Tyrosine is the amino acid and inhibitory neurotransmitter that often helps overcome depression. Clinical studies show that tyrosine controls medication-resistant depression. In a 1980 issue of the American Journal of Psychiatry, a study by Dr. Alan Gelenberg of Harvard Medical School discussed the role of tyrosine in the control of anxiety and depression. Dr. Gelenberg postulated that the lack of available tyrosine results in deficiency of the hormone norepinephrine at a specific location in the brain that relates to mood problems such as depression. Children given tyrosine supplementation demonstrated a marked improvement in mental performance and mood stability. Tyrosine, because of its role in assisting the body to cope physiologically with stress and building the bodys natural store of adrenaline, deserves to be called the stress amino acid. Stress exhaustion requires tyrosine. During periods of stress, in order to continue coping with stress physiologically, the brain requires tyrosine. Tyrosine aids children and young teens, as well as adults, with recurrent depression and mood disorders. In children, dosage ranges from 200 to 500 mg daily. Glycine Glycine is a nonessential amino acid, with the simplest structure of all the amino acids resembling glucose (blood sugar) and glycogen (excess sugar converted in the liver for storage). Glycine is sweet to the taste, can be used as a sweetener, and can mask bitterness and saltiness. Pure glycine dissolves readily in water. As the third major inhibitory neurotransmitter in the brain, glycine readily passes the blood-brain barrier. Studies by the late Carl Pfeiffer, MD, Ph.D., demonstrated glycine as an important factor in psychiatric disorders. Glycine decreases the craving for sugar, and, in many cases, can replace sugar on foods such as cereal. Glycine calms aggression in both children and adults. When combined with GABA and glutamine, glycine influences brain function by slowing down anxiety-related messages from the limbic system. As a very nontoxic amino acid, both children and adults can use glycine. Glycine can be mixed with other amino acids. Doses for a child range between 500 to 2,000 mg daily, divided. Magnesium Hyperactive or ADD children are almost always deficient in magnesium. Magnesium proves necessary for proper brain energy and is the first mineral depleted when anyone (child or adult) is under stress. Magnesium is a stress mineral, and deficiency can lead to hyperactive or ADD behavior. Magnesium plays a significant role in sugar metabolism and in the proper utilization of carbohydrates to create energy. Magnesium is so very important in a childs diet, especially if he displays hyperactive behavior, ADD, or other behavioral problems. Magnesium can be taken in liquid form, tablet, or capsule. When added to the ADD/ADHD diet, calming effects sometimes occur immediately. Most magnesium exists inside the cells where it activates enzymes necessary for the metabolism of carbohydrates and amino acids. In 1988, a study published in Alternative Medicine Review linked the development of ADHD to low blood-serum magnesium levels. A group of children followed for six months were given 200 mg of magnesium a day. Researchers noted remarkably decreased hyperactivity in the children. As a major nutrient needed by ADD/ADHD children and adults, magnesium is the number one stress mineral needed by the body. Magnesium is responsible for over three hundred enzyme functions. It cannot be stored by the body, and it must be taken daily. Symptoms of magnesium deficiency include asthma, migraines, eye twitches, anxiety, confusion, muscle spasms, irritability, depression, nervousness, fatigue, mood swings, PMS, hypertension, and insomnia. Calcium A calcium deficiency can also induce ADD/ADHD behavior. A child deficient in calcium exhibits irritability, sleep disturbances, anger, and inattentiveness. The first signs of a calcium deficiency include nervous stomach, cramps, tingling in the arms and legs, and painful joints. A calcium deficiency can also lead to ADD/ADHD behavior. Children sensitive to dairy products must receive daily calcium supplementation in capsule, chewable, or liquid form. Children up to 10 years of age need 1000 mg of calcium daily; adolescents need 1,200 to 1,500 mg daily. For those involved in sports activities, calcium supplementation is a must. Huperzine Recent research reports that Huperzine A improves mental function and learning in adolescents. Chinese researchers designed a study to determine the efficiency of Huperzine on memory and learning. The clinical study included 34 matched pairs of junior middle school students that had significant complaints of poor memory and difficulty in learning. In the double blind trial, half of the students received a placebo while the other half received Huperzine A for four weeks. Academic performance was measured before and after the clinical trial. The Huperzine group scored significantly better on standard memory tests without side effects. Huperzine A is an extract derived from Chinese club moss. Huperzine can be combined with amino acids and other nutrients. The suggested dosage is one 50 mcg capsule in the morning and in the evening for children aged 12 and over. This information is excerpted from my book Control Hyperactivity/ADD Naturally. Other resources include Is Ritalin Necessary? Both are available through: Pain & Stress Center 5282 Medical Dr. #160 San Antonio, TX 78229-6023

Labels: , , , , , , , , , , , ,

Tuesday, August 28, 2007

Testosterone, Aggression, Serotonin

Aggression: The Testosterone-Serotonin Link Forensic Psychiatric Division and 3Directorate, Be'er Yaakov Mental Health Center, Magen Prison, Ramleh, Israel 3Abarabnel Mental Health Center, Bat-Yam, Israel Both affiliated to Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel Key words: aggression, biological component, serotonin, testosterone Abstract The relevance of central neurotransmission to aggressive and impulsive behavior has become more evident due to extensive research in humans and animals. Among other findings, there are abundant data relating low serotonergic activity ± as measured by low cerebrospinal fluid 5-hydroxyindolacetic acid, and a blunted response of prolactin to fenfluramine ± to impulsive behavior. Many studies on testosterone activity show a relation between high plasma levels and a tendency towards aggression. It is hypothesized that the interaction between low serotonin and high testosterone levels in the central nervous system has a significant effect on the neural mechanisms involved in the expression of aggressive behavior. It seems that testosterone modulates serotonergic receptor activity in a way that directly affects aggression, fear and anxiety. Our survey reviews the main findings on serotonin, testosterone and the possible interaction between them with regard to these behavioral phenomena. IMAJ 2003;5:653±658 For Editorial see page 667 Aggression is a complex social behavior with many definitions. The most suitable for clinical implications is that proposed by Moyer [1]: ``An overt behavior with the intention of inflicting damage or other unpleasantness upon another individual.'' Aggression may occur in a broad spectrum of human behaviors ranging from an episodic, normal reaction to more generalized, pervasive manifes- tations in severe psychopathologies. In both humans and animals, the term aggression comprises behaviors that are non-homogenous for clinical phenomenology and neurobiologic features, making simple extrapolation from animal subtypes to humans not feasible. Nonetheless, clinical observations, experimental laboratory para- digms and cluster/factor-analytic statistics have been used in attempts to subdivide aggression in both humans and animals, thus broadening our understanding of the similar and non-similar factors that underlie aggression [2]. Violence has been defined as the physical force exerted for the purpose of violating, damaging, or abusing [3]. In humans, aggressive antisocial behavior, which is a complex phenomenon, is defined as a conduct indicating indifference to another's person or property such as criminal behavior, dishonesty or abuse [4]. Individual differences in the temperamental traits of impulsivity are relatively stable throughout life. Impulsivity is defined as actions that cannot be stopped or altered once they are initiated, even if the consequences of the action might be undesirable or unpleasant [5]. These traits are likely to result from interactions of biological and environmental factors. Brain structur- al abnormalities that are caused by genetic, nutritional-environ- mental factors may produce neuropsychologic dysfunctions. Neurotransmitters, hormones, cytokines, enzymes, growth factors, and signaling molecules are all involved in this complex neuro- circuitry that leads towards pathologic aggression. A neural circuit composed of several regions of the prefrontal cortex, amygdala, hippocampus, medial preoptic area, hypothalamus, anterior cingu- late gyrus, insular cortex, ventral striatum and other interconnected structures has been implicated in emotion regulation. Functional or structural abnormalities in one or more of these regions or in the interconnections among them can increase the susceptibility for impulsive aggression and violence [6]. Abnormalities of 5-hydroxy-tryptophan and noradrenergic func- tioning have been implicated in aggressive behavior. The role of dopamine in human studies requires further investigation. Most studies suggest that impulsive aggression is related to lower 5-HT levels in the central nervous system. While some studies show that increased levels of norepinephrine correlate with impulsive aggres- sion, others demonstrate an opposite relationship. The role of norepinephrine in impulsive aggressive behavior is still unclear [7]. Among the various factors implicated in aggression in humans and animals, a distinct link between testosterone and serotonin has been hypothesized as a major contributor [8]. In the present study we review recent findings on the effect of serotonin and testosterone on aggressive behavior and the possible link between them [Figure 1]. Testosterone Testosterone and other neurosteroids lead to sexual differentiation in the CNS. In laboratory animals it is clear that the CNS is 5-HT = 5-hydroxy-tryptophan IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 653 inherently female unless exposed to testicular hormones. Manip- ulation of the hormonal environment during perinatal development permanently alters both the structure and function of the CNS. Exposing females to testicular hormones masculinizes components of the CNS. Prenatal chemical castration or surgical castration of the male allows the development of a more female-like CNS. In mammals, the sexual differentiation of the CNS has a significant role in shaping sexual preference and other reproductive activities. In addition, it influences food intake and body weight, territorial marking and aggressive behavior, learning strategies, and play behavior. Most likely, in humans, other aspects of cognitive function are affected as well [9]. Testosterone appears to mediate its effects during a critical time period before and after birth, when it sensitizes certain neuronal circuits in the brain and guides the organization of the brain into a ``male-like'' pattern by inducing or preventing neural cell death. It has been suggested that as a result, in adulthood, when steroids stimulate these circuits again, aggressive behavior is elicited through modulation of specific neurotransmitter pathways. However, it must be remembered that hormones themselves do not directly cause behaviors; rather they induce chemical changes in certain neurons, affecting the likelihood of certain behavioral outcomes as a result of modulation of particular neural pathways [10]. Testosterone acts as a prohormone which, when converted into 5-alpha-dihydrotestosterone, acts on androgen receptors, or when converted to estradiol by the enzyme aromatase, acts on estrogen receptors. There is overwhelming evidence that most of the effects of testosterone in mediating aggression occur after aromatization [11]. Furthermore, the intensity of aggressive behavior was directly correlated with the aromatase activity in the posterior hypothala- mus [12]. Men, in general, are much more aggressive than women ± a fact that has led researchers to investigate possible links between levels of male hormones (particularly testosterone) and aggressive or criminal behavior. Testosterone may affect levels of aggression beginning early in life. In a study conducted among 28 male and 20 female preschoolers, children were videotaped while playing. Levels of aggression in social and play situations were observed and measurements of salivary testosterone levels evaluated. Results indicated a positive correlation in boys (but not in girls) between testosterone levels and serious aggression in social situations, but no correlation with playful aggression [13]. A study of 4,462 men revealed that the overall picture among the high testosterone men is one of delinquency, substance abuse and a tendency toward excess aggressive behavior. These men have more trouble with people like teachers while they are growing up, have more sexual partners, are more likely to show disciplinary problems during their military service and to have used ``hard'' drugs, particularly if they had a poor education and low incomes [14]. Measurements of testosterone saliva levels in 692 adult male prisoners showed that inmates who committed violent or sexual crimes had higher testosterone levels than inmates who were incarcerated for property crimes or drug abuse. This study also shows that inmates with higher testosterone levels violated more prison rules, especially those involving overt confrontation [15]. When salivary testosterone levels of young adult delinquents were compared with levels in a group of college students, matched for age, gender and race, the delinquent subjects had higher testosterone levels than the student controls, a finding that was true for both male and female subjects [16]. It can thus be concluded that high testosterone levels play a role in some criminal behavior, particularly when other risk factors such as low socioeconomic status are present. High testosterone levels have also been found in cases of antisocial behavior in a subtype of alcoholics. Levels of free testosterone, total testosterone, and sex hormone-binding globulin (which influences total testosterone concentration) were measured in 61 men undergoing forensic psychiatric examination. All subjects had been detoxified from drugs and alcohol while hospitalized or in prison. High concentra- tions of total testosterone and SHBG were related to type II alcoholism (a strongly genetically influenced type of alcoholism seen primarily in males, and associated with earlier onset, a more severe course, and criminality). In addition, total testosterone and SHBG were related to antisocial personality disorder and to socially deviant behavior, as reflected by scores on the Psychopathy Checklist, and free testosterone was strongly associated with the psychopathy-related scales of the Karolinska Scales of Personality [17]. In general, women have low testosterone levels. In order to learn more about the effects of this "male" hormone in females, saliva testosterone levels in 87 female inmates in a maximum security prison were compared with the violence levels of the crimes the subjects had committed, as well as the levels of aggressive dominant behavior they exhibited in prison. A direct link between testosterone and aggressively dominant behavior in prison was found. Further analysis indicated that increasing age is linked to reduced criminal violence and aggressive dominance in female prisoners, both directly and indirectly through lower levels of testosterone that come with age. Five women with the lowest testosterone levels were described by prison staff members to be "sneaky" and "treacherous." Observing the well-established link Reviews SHBG = sex hormone-binding globulin 654 M. Birger et al. IMAJ . Vol 5 . September 2003 between testosterone and dominance, it is hypothesized that when dominant high testosterone inmates face confrontation, they act openly and directly, while low testosterone inmates, because they are less dominant, need to be more ``sneaky'' in dealing with others [18]. The conclusion derived from accumulating evidence in humans and animals indicates that high testosterone levels are related to dominance-related aggression implicated in normal and pathologic behaviors. Serotonin The brainstem raphe 5-HT system is the most widely distributed neurotransmitter system in the brain. Serotonergic raphe neurons project diffusely to a variety of brain regions (e.g., cortex, amygdala, and hippocampus). In addition to its role as a neurotransmitter, 5- HT is an important regulator of morphogenetic activities during early brain development as well as during adult neurogenesis and plasticity, including cell proliferation, migration, differentiation and synaptogenesis [19]. In humans, non-human primates and other mammals, preclini- cal and clinical studies have accumulated an overwhelming body of evidence indicating that 5-HT signaling is a major modulator of emotional behavior, including anxiety and impulsivity as well as aggression, and integrates complex brain functions such as cognition, sensory processing and motor activity [20]. The diversity of these functions is due to the fact that 5-HT orchestrates the activity and interaction of several other transmitter systems. 5-HT may be viewed as a master-control neurotransmitter within a highly complex system of neural communication mediated by at least 14 pre- and postsynaptic receptor subtypes and subunits. 5-HT synthesizing and metabolizing enzymes, and the 5-HT transporter, play an important role in the regulation of 5-HT, which acts as a chemical messenger. 5-HT-mediated behaviors may be diversely expressed and range from minor personality accentuations (char- acterized by impulsivity, hostility, irritability, psychopathic deviance or violence, or by more clear-cut personality dysfunction such as antisocial, borderline, narcissistic and histrionic personality traits or disorders) to major psychiatric disturbances (suicidal behavior, overt aggressive behavior, intermittent explosive disorder, patholo- gic gambling, pyromania, bulimia, and some types of substance or alcohol abuse) [21]. One of the most replicated findings in psychobiology is the observation of lower 5-hydroxyindolacetic acid in the brain and cerebrospinal fluid of subjects with impulsive aggression and suicidal behavior. Low or lower than average 5-HIAA concentrations in cerebrospinal fluid have been reported in individuals who display inappropriate aggression as children, engage in frequent impulsive and violent criminal behavior, exhibit excessive alcohol abuse and dependence, and in high lethality suicide attempters as opposed to low lethality suicide attempters. Lifetime levels of aggression were found to be higher among individuals with lower CSF levels of 5-HIAA suffering from depression. In contrast, the dopamine and norepinephrine systems do not appear to be as significantly involved in suicidal acts, aggression, or depression. [22]. In a study of wild and captive primates, 49 male rhesus monkeys were studied for 4 years. During this time, young monkeys were undergoing a very dangerous period of life during which they migrated from their own groups to new social groups. Between 30% and 50% of the monkeys died during this period, often from violent encounters with other monkeys. (This particular colony of monkeys has no natural enemies.) At the beginning of the study, 5-HIAA levels were measured and the monkeys were divided into four groups: low, mid-low, mid-high, and high 5-HIAA. Twenty-seven of the monkeys were observed in the wild and the monkeys' aggressive acts were recorded. The aggressive acts of all 49 monkeys while in captivity, as well as the monkeys' fight-related scars and wounds, were also recorded. Low CSF 5-HIAA concentrations were predictive of the early death of 11 subjects of the monkey group that were either known or presumed dead. Direct observations of aggressive behavior showed that subjects that died had engaged in high rates of escalated aggression and exhibited a trend to engage in more overall aggression. Of the six dead monkeys whose bodies were recovered, all four who died violently had low 5-HIAA levels, while the two monkeys that died of illnesses had 5-HIAA levels similar to those of the surviving monkeys. While monkeys with low 5-HIAA levels were more violent than the high 5-HIAA monkeys, they also had other dangerous personality traits. They migrated at earlier ages when they were less prepared to defend themselves, were more likely to take life-threatening risks such as spontaneous jumping at dangerous heights when moving from tree to tree, and were most likely to be caught repeatedly in traps. [23]. The increased death rate among monkeys with low 5-HIAA levels is consistent with the results of a 1993 study conducted in a mixed- diagnosis group of 73 male psychiatric patients examined between 1976 and 1990 and diagnosed as suffering predominantly from schizophrenia and depression. Seven of these patients later died before the age of 40. All seven had markedly lower CSF 5-HIAA levels than the surviving patients, and six of the seven died either in homicides, suicides, or "suspicious" accidents [24]. An increase in plasma prolactin when the drug fenfluramine is administered is one measure of the responsiveness of the serotonergic system. The administration of the serotonin-releasing agent D-fenfluramine to 35 healthy subjects (20 females and 15 males) caused an inverse correlation between measures of serotonin function and measures of hostility and aggression in male subjects [25]. These data provide modest support for the theory of a link between reduced serotonergic activity and increased trait aggression in healthy males. No similar correlation was seen in female subjects. A fenfluramine challenge to 97 personality- disordered patients revealed that those with a history of self-injury or suicide attempts displayed evidence of abnormalities of the serotonergic system [26]. Research on deactivation of 5-HT receptors also indicated that 5-HT is connected to impulsivity and aggression-related behavior. The 5-HT1B receptor was the first subtype to have its gene deactivated. These receptors are located predominantly at presynaptic terminals where they can inhibit release of 5-HT. Wild-type and homozygous null mutant (5-HT1B) Reviews 5-HIAA = 5-hydroxyindolacetic acid CSF = cerebrospinal fluid IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 655 showed more rapid, more intense, and more frequent attacks when being intruded than the non-isolated male wild-type [27]. In contrast to 5-HT1B knockout in mice, 5-HT1A knockouts are less reactive and possibly less aggressive but show more anxiety-related behavior than control mice [28]. In humans, significant sib-pair linkage of antisocial alcoholism was associated with 5-HT1B gene HTR1B G861C polymorphism and the short-tandem repeat locus D6S284 [29]. The first step in 5-HT biosynthesis in 5-HT neurons is catalyzed by the rate-limiting enzyme tryptophan hydroxylase. Involvement of L-tryptophan availability and of TPH activity in impulsivity, aggressiveness, and associated suicidality has been reported in several studies of psychiatric patients or offender populations [30]. An increase was recently observed in aggressive responses on a free-operant laboratory measure of aggression following experi- mental tryptophan depletion in healthy males, supporting the hypothesis that low plasma tryptophan concentration and asso- ciated decrease in brain 5-HT facilitates aggression-related behavior [31]. Although some studies show a controversial trend, i.e., that elevated serotonergic activity leads to increased aggression [32], the majority of research data in humans and animal models do show a correlation between aggressive behavior and low CNS serotonergic activity. This is demonstrated by low CSF 5-HIAA levels, fenfluramine challenge, tryptophan depletion, and mice knockout paradigms. The relation between testosterone and serotonin A study that measured CSF testosterone and 5-HIAA showed that: . CSF free testosterone concentrations were positively correlated with overall aggressiveness, but not with measures of impulsiv- ity. . CSF 5-HIAA concentrations were negatively correlated with impulsive behavior and with severe, unrestrained aggression, but not with overall rates of aggression. High rates of impulsive behavior were positively correlated with severe, unrestrained aggression, but not overall rates of aggression. . Dimensional analyses showed that while subjects with low CSF 5-HIAA exhibited high rates of aggression, high CSF testosterone further augmented rates and intensity of aggression in subjects with low CSF 5-HIAA [33]. It is thus concluded that high CSF free testosterone concentrations are associated with competitive aggression, while low CSF 5-HIAA concentrations are associated with severe aggression, which results from impaired impulse control and perseverance [34]. The relationship between impulsivity, aggression, 5-HT function and testosterone in male offenders with personality disorders was investigated in 60 male offenders with personality disorders and 27 healthy controls, using the Special Hospital Assessment of Personality and Socialization score. Non-psychopaths and those with schizoid personality disorders according to SHAPS had enhanced 5-HT function (prolactin response to d-fenfluramine). Reduced 5-HT function was found in offenders with borderline personality disorders and those with a history of repeated self-harm or alcohol misuse. The 5-HT function was inversely correlated more strongly with impulsivity than with aggression. Plasma testosterone correlated positively with aggressive acts. The SHAPS primary psychopaths had lower initial cortisol and higher testosterone concentrations than controls [8]. Acute administration of testoster- one in male rats caused a significant increase in the content of 5- HT2A receptor mRNA and serotonin transporter mRNA in the dorsal raphe nucleus and the density of 5-HT2A receptor and serotonin binding sites in higher centers of the brain. The lack of effect of 5- alpha-dihydrotestosterone, a potent androgen that cannot be converted to estrogen, suggests that the action of testosterone depends upon its conversion to estrogen by aromatase. This may also explain why estrogen, but not testosterone, increased the density of 5-HT2AR binding sites in the caudate-putamen, a brain region where aromatase is scarce. These findings provide a potential topochemical handle with which to investigate testosterone/estrogen regulation of serotonin- related gene expression. The possible role of interactions between sex steroids and serotonin mechanisms might serve as an etiologic model to psychopathology leading to aggression [35]. The administration of paroxetine, a selective serotonin reuptake inhibitor, did not have any effect on night-time testosterone profiles in healthy male volunteers [36]. In a study examining the relationship between 5-HT, testosterone and alcoholism in the etiology of domestic violence, it was shown that: . Healthy controls and domestic violence in the non-alcoholic group differed in 5-HIAA concentrations and physical violence scores. . Healthy controls and domestic violence alcoholic groups differed in testosterone concentrations, alcohol dependence and physical violence scores. . The domestic violence non-alcoholic and domestic violence alcoholic groups differed in 5-HIAA, testosterone concentra- tions, physical violence scores and alcohol dependence [37]. Although studies link high levels of testosterone to aggression, this hormone alone does not account for aggressive behavior. In fact, successful athletes and businessmen tend to have high testosterone levels, without being any more violence-prone than their low testosterone counterparts, indicating that testosterone may not act alone in promoting aggression. Rather, aggressive men's behavior may be influenced by high testosterone levels combined with low levels of the brain chemical serotonin. Testosterone is linked more strongly to dominance in general than to aggression. High testosterone levels encourage dominance- seeking behaviors, which put the individual into situations in which frustration of dominance can occur. It is postulated that when a high testosterone man is frustrated in his attempts to achieve dominance, serotonin comes into play, because low serotonin activity is associated with hyper-responsiveness to aversive stimuli and therefore results in a greater likelihood of an intensely negative emotional reaction and, thus, a greater chance of aggressive behavior. It is speculated that the hypothalamus and amygdala, which are prominently associated with both testosterone and Reviews TPH = tryptophan hydroxylase SHAPS = Special Hospital Assessment of Personality and Socialization 656 M. Birger et al. IMAJ . Vol 5 . September 2003 serotonin, play a key role in aggressive responses to situations in which efforts at dominance are frustrated. In comparison to non- aggressive animals, aggressive animals were found to have lower serotonin levels in the hypothalamus and the amygdala. Testoster- one action in both of these brain structures was shown to increase aggression in various animal species [38]. Conclusions Biological influences are not the only pathway leading to individual differences in personality dimensions, behavior, and psychopathol- ogy. Complex traits are most likely generated by a complex interaction of environmental and experiential factors with a number of biological factors, among which testosterone and serotonin play a major role. Recent genetic studies on 5-HT receptors, transpor- ters, and modifying enzymes have shown that although these substances have only a modest impact, they affect many develop- mental processes throughout ontogeny as well as compensatory mechanisms. The therapeutic application of these findings includes the use of agents that increase 5-HT, either by facilitating its release such as fenfluramine or by blocking its reuptake by the various selective serotonin reuptake inhibitors [39]. Chemical castration by antian- drogenic agents, although inefficient for treating general aggres- sion, is used for the treatment of paraphilic sex offenders [40]. It is becoming increasingly evident that many neurotransmitters and hormones are expressed at early periods of neural development and it is likely that they participate in the structural organization of the nervous system. A major challenge is therefore the identifica- tion of specific neural mechanisms that underlie aggressiveness and impulsivity for the purpose of early identification, prevention and the treatment of individuals who are prone to violent acts. References 1. Moyer K. Kinds of aggression and their physiological basis. In: Buglass R, Bowden P, eds. Principles and Practice of Forensic Psychiatry. Community and Behavioural Biology. Part A. Edinburgh: Churchill Livingstone, 1968. 2. Scarpa A, Raine A. Psychophysiology of anger and violent behavior. Psychiatr Clin North Am 1997;20:375±94. 3. The American Heritage Dictionary of the English Language. 4th edn. New York: Houghton Mifflin, 2000. 4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association, 1994. 5. Logan GD, Schachar RJ, Tannock R. Impulsivity and inhibitory control. Psych Sci 1997;8:60±4. 6. Davidson RJ. Dysfunction in the neural circuitry of emotion regulation ± a possible prelude to violence. Science 2000;289:591±4. 7. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000;23:11±25. 8. Dolan M, Anderson IM, Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 2001;178:352±9. 9. Gorski RA. Development of the cerebral cortex. XV: Sexual differentiation of the central nervous system. J Am Acad Child Adolesc Psychiatry 1998;37:1337±9. 10. Ewen B. Endocrine effects on the brain and their relationship to behavior. In: Siegel G, ed. Basic Neurochemistry. 5th edn. London: Raven Press, 1994:1007±26. 11. Schlinger BA, Callard GV. Aromatization mediates aggressive behavior in quail. Gen Compar Endocrinol 1990;79:39±53. 12. Schlinger BA, Callard GV. Aromatase activity in quail brain: correlation with aggressiveness. Endocrinology 1989;124:437±43. 13. Sanchez-Martin E, Fano L, Ahedo J, et al. Relating testosterone levels and free play social behavior in male and female preschool children. Psychoneuroendocrinology 2000;8:773±83. 14. Dabbs JM, Morris R. Testosterone, social class, and antisocial behavior in a sample of 4,462 men. Psychol Sci 1990;1:209±11. 15. Dabbs JM, Carr TS, Frady, Rl, et al. Testosterone, crime, and misbehavior among 692 male prison inmates. Person Individ Diff 1995;18:627±33. 16. Banks T, Dabbs JM. Salivary testosterone and cortisol in a delinquent and violent urban subculture. J Soc Psychol 1996;136:49±56. 17. Stalenheim EG, Eriksson E, von Knorring L, et al. Testosterone as a biological marker in psychopathy and alcoholism. Psychiatr Res 1998;77:79±88. 18. Dabbs JM, Hargrove MF. Age, testosterone, and behavior among female prison inmates. Psychosom Med 1997;59:477±80. 19. Azmitia EC, Whitaker-Azmitia PM. Development and adult plasticity of serotonergic neurons and their target cells. In: Baumgarten HG, Gothert M, eds. Serotonergic Neurons and 5-HT Receptors in the CNS. New York: Springer, 1997:1±39. 20. Westenberg HG, Murphy DL, Den Boer JA. Advances in the Neurobiology of Anxiety Disorders. New York: Wiley, 1996. 21. Staner L, Mendlewicz J. Heredity and role of serotonin in aggressive impulsive behavior. Encephale 1998;24:355±64. 22. Asberg M. Neurotransmitters and suicidal behavior: the evidence from cerebrospinal fluid studies. Ann NY Acad Sci 1997;836:158±81. 23. Higley JD, Mehlman PT, Higley SB, et al. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 1996;53: 537±43. 24. Faustman WO, Ringo DL, Faull KF. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Br J Psychiatry 1993;163:519±21. 25. Cleare AJ, Bond, AJ. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatr Res 1997;69:89±95. 26. New AS, Trestman RL, Mitropolou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatr Res 1997;69:17±26. 27. Ramboz S, Saudou F, Amara DA, et al. 5-HT1B receptor knock out- behavioral consequences. Behav Brain Res 1996;73:305±12. 28. Zhuang X, Gross C, Santarelli L, et al. Altered motional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharma- cology 1999;21:52±60S. 29. Lappalainen J, Long JC, Eggert M, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998;55:989±94. 30. LeMarquand DG, Benkalfat C, Pihl RO, et al. Behavioral inhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry 1999;156:1771±9. 31. Wingrove J, Bond AJ, Cleare AJ, et al. Trait hostility and prolactin response to tryptophan enhancement/depletion. Neuropsychobiology 1999;40:202±6. 32. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527±31. 33. Higley JD, Mehlman PT. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 1996;40:1067±82. 34. Higley JD, Mehlman PT. Comment on the article: CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors Biol Psychiatry 1997;42:305±7. 35. Fink G, Sumner B, Rosie R, et al. Androgen actions on central serotonin Reviews IMAJ . Vol 5 . September 2003 Aggression: The Testosterone-Serotonin Link 657 neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 1999;105:53±68. 36. Schlosser R, Wetzel H, Dorr H, et al. Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers. Psychoneuroendocrinology 2000;25:377±88. 37. George DT, Umau JC, Philips MJ, et al. Serotonin, testosterone and alcohol in the etiology of domestic violence. Psychiatr Res 2001;104:27± 37 38. Bernhardt PC. Influences of serotonin and testosterone in aggression and dominance: convergence with social psychology. Curr Direc Psychol Sci 1997;6:44±8. 39. Coccaro EF, Kavoussi RJ. Fluxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 1997;54:1081±8. 40. Rosler A, Witztum E. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 2000;18:43±56. Correspondence: Dr. M. Birger, Forensic Psychiatric Services, Magen Prison, P.O. Box 2058, Ramleh 72100, Israel. Phone: (972-8) 977-6142 Fax: (972-8) 977-6141 email: bymoshe@beer-ness.health.gov.il Reviews

Labels: , ,